Other reaction to severe stress, and adjustment disorders

F5_STRESSOTH

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F43 Hospital discharge: ICD-9 — 309 Hospital discharge: excluded ICD-10 — F43.1 Cause of death: ICD-10 — F43 Cause of death: ICD-9 — 309 Cause of death: excluded ICD-10 — F43.1 2 out of 7 registries used, show all original rules.	19677
4. Check minimum number of events None	19677
5. Include endpoints None	19677
6. Filter based on genotype QC (FinnGen only)	19677

Control definitions (FinnGen only)

Control exclude: F5_NEUROTIC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F40-F48
Name in latin: Reactio e stressu severi

NAME	F5_STRESSOTH
CONTROL_EXCLUDE	F5_NEUROTIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F43
HD_ICD_9	309
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	F431
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F43
COD_ICD_9	309
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	F431
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other reaction to severe stress, and adjustment disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	161189	94365	65650
Only index persons	149791	89662	60129
Unadjusted period prevalence (%)
Whole population	2.34	2.70	1.83
Only index persons	2.89	3.30	2.30
Median age at first event (years)
Whole population	33.89	37.12	29.19
Only index persons	33.12	36.43	28.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	19677	13739	5938
Unadjusted period prevalence (%)	4.06	4.68	2.62
Median age at first event (years)	39.38	39.46	39.18

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17747: Matched controls
177468

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

22.3

323.0

960

454

F51.0

ICD-10 Finland

Nonorganic insomnia

2.9

323.0

3158

12352

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

10769

76914

P29

ICPC

Psychological sympt/compl other

4.2

323.0

1709

4437

P76

ICPC

Depressive disorder

4.3

323.0

1837

4615

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

323.0

7251

41770

N06AX11

ATC

mirtazapine; oral

4.4

323.0

8305

29343

N02AX02

ATC

tramadol; systemic, rectal

2.2

323.0

7174

41881

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

11.3

323.0

893

825

N03AX09

ATC

lamotrigine; oral

7.1

323.0

1751

2705

N02AA05

ATC

oxycodone; systemic

3.0

323.0

2161

7823

N06AB05

ATC

paroxetine; oral

4.9

323.0

1657

3649

N05AA02

ATC

levomepromazine; systemic

8.3

323.0

1183

1517

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

9.7

323.0

2379

2793

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.3

323.0

1827

5886

N03AG01

ATC

valproic acid; systemic, rectal

5.3

323.0

1760

3601

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.7

323.0

1859

3542

P01

ICPC

Feeling anxious/nervous/tense

3.7

323.0

3296

10365

P03

ICPC

Feeling depressed

3.5

323.0

2670

8467

C07AA05

ATC

propranolol; systemic

2.6

323.0

4167

18558

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

8.4

323.0

3395

4869

F43.02

ICD-10 Finland

Acute stress reaction severe

44.3

323.0

429

N06AX21

ATC

duloxetine; oral

4.2

323.0

2833

7716

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

7.3

323.0

829

1177

N05AH03

ATC

olanzapine; systemic

7.2

323.0

2055

3154

N05CD07

ATC

temazepam; oral

4.4

323.0

2274

5794

F41.1

ICD-10 Finland

Generalized anxiety disorder

11.4

323.0

1718

1653

F32.9

ICD-10 Finland

Depressive episode, unspecified

7.9

323.0

5217

8912

N05CF01

ATC

zopiclone; oral

3.5

323.0

6731

26387

F41.00

ICD-10 Finland

Moderate panic disorder

52.8

323.0

568

111

F41.09

ICD-10 Finland

UNS Panic Syndrome

13.1

323.0

897

719

F43.01

ICD-10 Finland

Acute stress reaction moderate

19.2

323.0

1201

667

N05BA04

ATC

oxazepam; oral

5.4

323.0

7170

19671

N06AB06

ATC

sertraline; oral

5.3

323.0

3461

7797

N06AB10

ATC

escitalopram; oral

4.0

323.0

5951

19929

F29

ICD-10 Finland

Unspecified nonorganic psychosis

6.6

323.0

1231

1970

N05AX12

ATC

aripiprazole; systemic

6.3

323.0

1214

2037

N05BA01

ATC

diazepam; systemic, rectal

4.5

323.0

3302

8564

N05AX08

ATC

risperidone; systemic

5.4

323.0

1794

3650

T36

ICD-10 Finland

Poisoning by systemic antibiotics

10.7

323.0

2013

2102

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

10.3

323.0

3585

4266

F61.0

ICD-10 Finland

Mixed personality disorders

16.3

323.0

735

470

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

18.9

323.0

526

287

N06AX03

ATC

mianserin; oral

6.0

323.0

1161

2057

F34.1

ICD-10 Finland

Dysthymia

7.3

323.0

1094

1582

F43.2

ICD-10 Finland

Adjustment disorders

13.5

323.0

955

746

R51.80

ICD-10 Finland

Headache

2.6

323.0

3425

15075

N05BA06

ATC

lorazepam; systemic, sublingual

5.6

323.0

1103

2076

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

11.5

323.0

1642

1554

F43.00

ICD-10 Finland

Acute stress reaction mild

22.1

323.0

2194

1126

N05AH04

ATC

quetiapine; oral

7.1

323.0

5967

11860

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

7.9

323.0

3619

5593

SPAT1240

SPAT

Therapeutic discussion

3.3

323.0

3124

10724

N05CF02

ATC

zolpidem; oral

2.7

323.0

3794

16138

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

10.0

323.0

862

902

N05BA12

ATC

alprazolam; oral

4.3

323.0

2502

6455

N06AX16

ATC

venlafaxine; oral

5.2

323.0

4501

10830

Z71.8

ICD-10 Finland

Other specified counselling

2.1

323.0

4861

26532

N03AX12

ATC

gabapentin; oral

2.9

323.0

3019

11683

N06AX12

ATC

bupropion; oral

5.0

323.0

1960

4269

F43.29

ICD-10 Finland

Adaptation disorder UNS

48.5

323.0

2588

622

F43.0

ICD-10 Finland

Acute stress reaction

4.4

323.0

1684

4129

N06AB04

ATC

citalopram; systemic

4.6

323.0

5956

17405

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

10.9

323.0

1841

1861

N05BE01

ATC

buspirone; oral

8.6

323.0

781

944

N02BE01

ATC

paracetamol; systemic, rectal

2.1

323.0

14742

123659

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

51.3

323.0

5630

1592

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

9.3

323.0

2821

3539

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

6.3

323.0

1496

2550

N07BB01

ATC

disulfiram; oral

5.6

323.0

1230

2348

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

10.8

323.0

766

737

A03FA01

ATC

metoclopramide; systemic, rectal

2.3

323.0

3760

18801

N03AE01

ATC

clonazepam; systemic

5.3

323.0

1420

2887

F43.8

ICD-10 Finland

Other reactions to severe stress

14.3

323.0

1561

1191

F43.1

ICD-10 Finland

Post-traumatic stress disorder

21.5

323.0

1193

594

N06AB03

ATC

fluoxetine; oral

4.6

323.0

3440

8858

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.6

323.0

2213

4418

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

8.2

323.0

927

1179

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

323.0

4565

24312

N06AA09

ATC

amitriptyline; systemic

3.3

323.0

1876

6062

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

129.0

323.0

2035

178

N06AX26

ATC

vortioxetine; oral

4.1

323.0

1462

3800

R53

ICD-10 Finland

Malaise and fatigue

2.4

323.0

3822

18009

F43.23

ICD-10 Finland

Adaptive disorder with other mental disorder

47.8

323.0

434

N03AX16

ATC

pregabalin; oral

2.9

323.0

4713

19383

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

8.5

323.0

1037

1292

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

323.0

6613

39202

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

107.5

323.0

1231

123

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.4

323.0

4374

6621

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

10.6

323.0

860

851

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

9.5

323.0

801

875

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

9.7

323.0

954

1033

IGY02

NOMESCO Finland

Psychiatric monitoring contact

9.5

323.0

726

793

P74

ICPC

Anxiety disorder/anxiety state

5.5

323.0

1117

2138

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

9.8

323.0

907

966

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

10.5

323.0

1940

2052

F32.1

ICD-10 Finland

Moderate depressive episode

3.8

323.0

1550

4337

AA1AD

NOMESCO Finland

CT of head and brain

2.5

323.0

3619

16449

F99

ICD-10 Finland

Mental disorder, not otherwise specified

8.7

323.0

755

902

F43.25

ICD-10 Finland

Adaptive disorder with mixed mental disorder and behavioral disorder

160.6

323.0

362

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

+∞

323.0

493

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

22.0

323.0

739

349

F60.9

ICD-10 Finland

Personality disorder, unspecified

18.9

323.0

661

363

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

20.6

323.0

1926

1040

N05AF03

ATC

chlorprothixene; systemic

7.6

321.5

791

1082

IGY99

NOMESCO Finland

Other psychiatric treatment contact

10.8

317.4

635

609

M79.6

ICD-10 Finland

Pain in limb

1.9

317.2

6119

37897

M54.5

ICD-10 Finland

Low back pain

1.9

312.6

6058

37531

3092D

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[AHDISTUNEISUUTENA ILMENEVÄ SOPEUTUMISHÄIRIÖ]

+∞

309.2

296

R06.0

ICD-10 Finland

Dyspnoea

2.2

306.8

3846

19928

F40.1

ICD-10 Finland

Social phobias

12.9

305.3

559

446

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.1

305.1

1908

6722

3092E

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]

+∞

299.8

287

F41.8

ICD-10 Finland

Other specified anxiety disorders

6.9

298.9

784

1176

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.2

298.9

701

889

N06AA12

ATC

doxepin; systemic

4.8

297.5

1067

2343

N06AX05

ATC

trazodone; oral

7.6

295.1

725

988

N05AB03

ATC

perphenazine; systemic, rectal

5.9

288.9

856

1509

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

287.9

3959

21274

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

9.6

286.8

610

655

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

282.2

5928

37461

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

8.6

280.2

637

767

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

275.6

1698

5899

F10.20

ICD-10 Finland

Alcohol dependence currently independent

9.0

275.6

609

699

SPAT1307

SPAT

Psychosocial counselling and guidance

3.0

274.7

1722

6053

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

273.3

2160

8788

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

271.5

4521

26153

A06AD11

ATC

lactulose; oral

2.8

267.2

1964

7645

F31.8

ICD-10 Finland

Other bipolar affective disorders

8.2

266.1

622

783

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

18.5

265.0

419

232

F32

ICD-10 Finland

Depressive episode

3.6

264.4

1319

3911

F43.28

ICD-10 Finland

Adaptive disorder with other predominant symptoms

27.5

264.4

369

137

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

264.3

7355

50711

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

262.8

3307

17008

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

260.3

2398

10604

N05AN01

ATC

lithium; oral

6.6

257.1

695

1085

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

251.6

2378

10641

P99

ICPC

Psychological disorders other

5.6

246.9

765

1421

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

9.2

246.7

537

600

F39

ICD-10 Finland

Unspecified mood [affective] disorder

7.8

243.3

584

766

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

242.5

1700

6405

WX110

NOMESCO Finland

Local anesthesy

1.7

241.9

12424

101705

A02BC01

ATC

omeprazole; systemic

1.9

241.6

4253

24930

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

240.8

5497

35268

N06AG02

ATC

moclobemide; oral

4.5

239.8

904

2080

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

9.5

239.2

512

555

R42

ICD-10 Finland

Dizziness and giddiness

2.1

239.2

3117

16200

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

7.5

238.6

591

813

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

238.5

7725

55196

S06.0

ICD-10 Finland

Concussion

2.6

236.7

2004

8430

C07AB07

ATC

bisoprolol; oral

1.8

235.4

5712

37315

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

234.0

9815

75357

G44.2

ICD-10 Finland

Tension-type headache

2.2

234.0

2612

12650

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

233.9

1357

4496

R11

ICD-10 Finland

Nausea and vomiting

2.9

232.4

1560

5710

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.8

232.0

1611

6024

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.9

230.5

802

1697

L03

ICPC

Low back symptom/complaint

1.9

227.3

4181

24809

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

227.1

1757

7013

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

226.5

2994

15613

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

226.5

8791

65775

SPAT1254

SPAT

Administration of medicine

2.3

226.3

2401

11337

A04

ICPC

Weakness/tiredness general

2.3

225.5

2283

10533

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

9.0

225.0

495

563

Z00.0

ICD-10 Finland

General medical examination

2.0

224.7

3221

17366

C03CA01

ATC

furosemide; systemic

2.1

223.4

2844

14584

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

220.2

4318

26158

P06

ICPC

Sleep disturbance

2.5

218.4

1924

8253

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.0

217.6

478

542

N06AX22

ATC

agomelatine; oral

6.3

217.5

611

1002

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

8.9

217.2

482

556

P01AB01

ATC

metronidazole; oral, rectal

1.7

216.6

6792

47628

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

216.4

2994

15883

H02AB06

ATC

prednisolone; systemic

1.7

216.3

7349

52724

J01DB01

ATC

cefalexin; oral

1.8

215.2

14275

123462

R50.9

ICD-10 Finland

Fever, unspecified

2.2

214.3

2468

12083

R03AC02

ATC

salbutamol; inhalant

1.6

213.6

9060

68989

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

213.5

1064

3138

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

212.6

3542

20192

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

212.1

2972

15835

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

211.8

12805

107303

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.9

211.4

555

830

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

211.3

4349

26719

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

210.8

4283

26192

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

210.2

2840

14897

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.3

208.3

482

596

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.1

202.7

521

756

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

12.7

201.8

371

298

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

201.4

2045

9412

K02.1

ICD-10 Finland

Caries of dentine

1.6

199.9

10480

83712

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

9.9

199.2

415

428

L28

ICPC

Limited function/disability (L)

2.3

198.0

1989

9100

XA800

NOMESCO Finland

Neuropsychological investigation

3.7

197.7

915

2536

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

197.4

3132

17468

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

197.1

4340

27153

A02BC05

ATC

esomeprazole; systemic

1.7

195.8

6229

43496

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

195.5

3193

17995

S18

ICPC

Laceration/cut

1.7

195.4

6014

41597

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

193.0

1516

6077

R52.2

ICD-10 Finland

Other chronic pain

4.5

192.6

725

1661

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

22.0

191.0

284

131

SPAT1301

SPAT

No procedures

1.7

190.9

4902

32113

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.3

188.5

753

1827

A01

ICPC

Pain general/multiple sites

2.8

187.0

1295

4809

R4110

NOMESCO Finland

Physiotherapy

1.8

186.6

3999

24725

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

7.8

185.0

443

578

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.9

184.8

546

954

ZX120

NOMESCO Finland

Intravenous

2.5

183.6

1594

6747

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

9.4

183.3

392

424

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

8.3

182.7

423

523

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

182.4

2614

13964

SPAT1216

SPAT

Assessment of functional ability

2.3

182.1

1934

9066

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

181.8

1059

3502

P15

ICPC

Chronic alcohol abuse

4.9

180.7

620

1289

F41.3

ICD-10 Finland

Other mixed anxiety disorders

9.0

180.2

396

449

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

179.9

2769

15205

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.8

179.1

429

560

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

9.5

178.9

382

412

N05BA02

ATC

chlordiazepoxide; systemic

6.3

178.8

501

818

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.8

178.6

532

939

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

178.0

2829

15721

F32.8

ICD-10 Finland

Other depressive episodes

7.2

176.9

446

629

3094A

ICD-9 Finland

Adjustment reaction, With mixed disturbance of emotions and conduct

+∞

176.3

169

SPAT1263

SPAT

Sampling

1.6

174.5

7071

52164

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

174.4

6135

43644

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

173.4

4203

26907

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

172.9

1972

9542

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

172.3

5090

34508

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

171.1

8570

66483

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

170.4

3372

20216

N01

ICPC

Headache

2.1

169.8

2203

11269

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.9

169.5

1092

3864

R52.9

ICD-10 Finland

Pain, unspecified

2.5

168.6

1445

6063

WX290

NOMESCO Finland

Other blockade of nerve

1.6

168.4

8439

65373

SPAT1310

SPAT

Counselling related to known health issue

1.7

168.4

5156

35254

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

8.6

167.8

379

450

A02BA02

ATC

ranitidine; systemic

2.0

167.5

2631

14521

M79.1

ICD-10 Finland

Myalgia

2.0

166.4

2284

11952

N06AB08

ATC

fluvoxamine; oral

4.9

166.0

570

1185

R02

ICPC

Shortness of breath/dyspnoea

2.2

166.0

1804

8526

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

165.3

1340

5447

T74.1

ICD-10 Finland

Physical abuse

5.0

165.3

565

1169

EBA00

NOMESCO Finland

Extraction of tooth

1.6

164.9

5566

39016

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

163.8

1749

8198

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

190.7

163.1

170

A28

ICPC

Limited function/disability NOS

2.4

163.0

1507

6574

UJF32

NOMESCO Finland

Coloscopy

1.8

162.8

3402

20725

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

161.6

2090

10663

M03BX02

ATC

tizanidine; oral

1.5

161.4

10567

86747

L17

ICPC

Foot/toe symptom/complaint

1.7

160.9

3737

23527

D11

ICPC

Diarrhoea

2.0

160.1

2185

11396

J01FF01

ATC

clindamycin; systemic

1.7

158.3

4271

28085

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

9.9

158.0

329

339

R74

ICPC

Upper respiratory infection acute

1.6

157.7

5643

40042

P02

ICPC

Acute stress reaction

2.8

156.5

1080

3989

M25.5

ICD-10 Finland

Pain in joint

1.6

155.9

4705

31899

L01

ICPC

Neck symptom/complaint

2.0

155.8

2310

12441

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

155.2

6602

48845

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

10.5

154.9

312

302

A02BC03

ATC

lansoprazole; oral

1.7

154.3

4074

26589

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

153.7

1006

3590

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

153.5

1358

5783

J01MA12

ATC

levofloxacin; systemic

1.9

153.2

2513

14050

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

153.1

1476

6570

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

152.3

1082

4066

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

5.2

152.1

495

969

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.6

151.8

409

633

N06BA04

ATC

methylphenidate; oral

4.2

151.7

606

1468

SPAT1260

SPAT

Consultation of another employee

1.9

151.6

2734

15805

F41.01

ICD-10 Finland

Severe panic disorder

65.8

151.2

176

SPAT1234

SPAT

Support of social functional capacity

3.6

151.2

723

2052

N05AD01

ATC

haloperidol; systemic

4.9

150.5

521

1092

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

149.3

2239

12093

P25

ICPC

Phase of life problem adult

2.9

149.1

970

3447

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

149.1

1316

5594

R05

ICPC

Cough

1.7

148.2

3594

22838

N06AA06

ATC

trimipramine; systemic

5.0

147.8

500

1022

N03AF01

ATC

carbamazepine; oral, rectal

3.2

147.7

827

2650

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

146.1

3762

24316

RS221

NOMESCO Finland

6.4

146.0

401

637

F10.24

ICD-10 Finland

Alcohol depence active use

7.3

145.9

364

505

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

145.7

2003

10449

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

145.0

4125

27413

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

48.3

144.5

177

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

143.9

2221

12117

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

143.2

9258

74805

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

143.1

3679

23749

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

141.9

1981

10390

-1

NOMESCO Finland

1.5

141.6

6137

45317

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

141.3

3160

19554

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

141.2

1613

7770

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

140.5

5386

38604

J01MA02

ATC

ciprofloxacin; systemic

1.6

140.0

5396

38717

N30.0

ICD-10 Finland

Acute cystitis

1.9

139.4

2203

12115

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

4.5

138.8

517

1169

R07.3

ICD-10 Finland

Other chest pain

2.3

138.1

1385

6275

J01DA01

ATC

[U] cefalexin; systemic

1.5

138.1

10296

85453

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.4

138.1

708

2123

D01

ICPC

Abdominal pain/cramps general

2.0

137.8

1930

10129

G47.3

ICD-10 Finland

Sleep apnoea

1.8

137.0

2939

17932

WX002

NOMESCO Finland

Sedation and analgesia

1.8

136.8

2670

15799

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

9.9

136.4

283

290

F93.89

ICD-10 Finland

Other childhood emotional disorders

11.6

136.1

260

227

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

134.9

3332

21204

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

134.2

808

2722

UKC02

NOMESCO Finland

Cystoscopy

2.1

134.0

1726

8745

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

11.9

133.7

252

214

R1250

NOMESCO Finland

Evaluation of functional capability

4.8

133.5

470

1003

A04AA01

ATC

ondansetron; systemic, rectal

2.5

133.1

1106

4541

R4140

NOMESCO Finland

Psychotherapy

13.0

132.5

240

187

WX892

NOMESCO Finland

Monitored bed care

2.6

130.9

1067

4334

N03AX11

ATC

topiramate; oral

3.7

129.6

611

1712

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

14.4

129.5

224

157

JN4BD

NOMESCO Finland

Extensive body CT

2.2

128.7

1398

6569

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

25.5

128.3

182

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

127.1

1657

8431

SPAT1252

SPAT

Overall medication plan or its review

2.8

126.6

898

3362

J01AA02

ATC

doxycycline; systemic

1.5

126.0

12296

106853

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

10.7

125.4

249

235

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.4

125.2

476

1098

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

125.1

120

F60.8

ICD-10 Finland

Other specific personality disorders

12.4

125.0

231

188

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

8.4

125.0

284

341

R4120

NOMESCO Finland

Occupational therapy

2.5

124.7

1026

4188

J02AC01

ATC

fluconazole; systemic

1.5

124.1

7026

54547

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3033658) Prothrombin time (PT) actual/Normal

5727

35116

1.89

323.31

5.0

3.6

95.3

94.5

1.50

5551

34191

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

472

656

7.35

320.43

1.8

2.0

—

(3027944) Amphetamines [Presence] in Urine

2105

8786

2.56

317.17

2.8

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11005

70651

2.27

307.65

8.0

5.6

9.7

10.7

umol/l

12.95

10436

66836

(3016879) Cocaine [Presence] in Urine

2088

7971

2.81

307.65

3.0

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3869

18880

2.31

307.65

1.8

1.7

1174.3

1184.8

nmol/l

0.28

3073

14617

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

10354

62177

2.40

307.65

8.5

6.2

1.2

mmol/l

2.40

8887

52521

(3021589) Normoblasts [#/volume] in Blood

9740

67987

1.86

307.65

12.1

8.3

0.0

e9/l

0.21

8183

56119

(3021960) Folate [Moles/volume] in Serum or Plasma

4702

26226

2.04

307.65

1.6

1.5

19.7

20.7

nmol/l

4.27

4179

22889

(3011288) Drugs identified in Urine by Screen method

1824

5143

3.81

307.65

4.0

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1904

6345

3.22

307.65

3.0

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15503

126007

2.09

307.65

4.9

3.9

14.4

14.5

pmol/l

6.26

14454

116837

(3000764) Benzodiazepines [Presence] in Urine

2174

8772

2.66

307.65

2.9

1.7

—

(3022096) Basophils/100 leukocytes in Blood

10035

68776

1.94

307.65

8.2

5.9

0.7

4.21

9454

64594

(36304419) Bacteria [Presence] in Urine

5959

35857

1.95

307.65

3.6

2.7

—

(3001604) Monocytes [#/volume] in Blood

10963

75616

2.02

307.65

8.0

5.7

0.6

e9/l

3.47

9691

66673

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7218

43249

2.06

307.65

3.4

2.4

54.7

57.6

u/l

4.60

6746

40167

(4198724)

497

590

8.62

307.65

2.3

2.2

—

(3000850) Epithelial cells [#/volume] in Urine

4739

27043

1.99

307.65

3.2

2.4

7.3

6.6

e6/l

0.98

4200

23494

(42870588) Differential panel, method unspecified - Blood

7795

48956

1.98

307.65

7.6

5.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2892

13265

2.38

307.65

2.4

2.1

369.6

374.7

nmol/l

0.63

2652

12316

(3030467) Casts [#/volume] in Urine by Automated count

6021

35969

1.97

307.65

3.7

2.8

0.3

e6/l

1.33

4671

26364

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

7439

47167

1.93

307.65

4.1

2.9

—

0.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7381

46534

1.94

307.65

4.1

2.8

58.0

53.0

ng/l

0.06

4455

24872

(3028300) Cannabinoids [Presence] in Urine

2183

8872

2.64

307.65

3.0

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

10317

71179

1.94

307.65

8.1

5.8

2.8

3.83

9729

66807

(3019550) Sodium [Moles/volume] in Serum or Plasma

18027

157403

2.73

307.65

20.1

11.2

139.5

139.7

mmol/l

22.95

17724

153170

(3002030) Lymphocytes/100 leukocytes in Blood

10560

74627

1.90

307.65

8.1

5.8

28.9

29.4

4.29

9943

70244

(3032080) INR in Blood by Coagulation assay

7713

48190

1.99

307.65

8.3

6.6

1.1

1.2

inr

2.04

2664

15098

(3013707) Erythrocyte sedimentation rate by Westergren method

14244

113193

1.94

307.65

4.8

3.7

10.9

10.1

mm/h

11.05

13333

106228

(3023368) Bacteria identified in Blood by Culture

5642

31185

2.13

307.65

5.4

3.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7921

49919

1.98

307.65

4.2

3.0

31.6

32.4

u/l

0.45

7536

47611

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14960

111006

2.45

307.65

10.1

6.8

76.9

74.8

u/l

6.78

14269

104921

(3031040) Bacteria [#/volume] in Urine by Automated count

12999

99570

1.90

307.65

5.6

3.7

771.8

1476.0

e6/l

1.46

167

1164

(3006315) Basophils [#/volume] in Blood

11001

75875

2.02

307.65

8.0

5.7

0.0

e9/l

0.45

9711

66845

(3026782) Osmolality of Urine

4476

24803

2.04

307.65

3.3

2.5

526.4

546.5

mosm/kgh2o

6.89

3918

21078

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3664

18617

2.19

307.65

2.1

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7893

49965

1.97

307.65

2.0

1.8

97.2

98.3

pmol/l

1.29

4333

26406

(3009466) Valproate [Moles/volume] in Serum or Plasma

753

1537

5.05

307.65

5.4

367.4

377.4

umol/l

0.95

662

1359

(3013115) Eosinophils [#/volume] in Blood

11249

78701

2.00

307.65

8.6

5.9

0.2

e9/l

0.30

10087

70427

(3013650) Neutrophils [#/volume] in Blood by Automated count

12225

87359

2.05

307.65

12.5

8.4

4.1

4.0

e9/l

5.15

10909

77003

(3019069) Monocytes/100 leukocytes in Blood

10369

71581

1.95

307.65

8.3

6.1

8.2

8.3

1.13

9815

67681

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6438

36830

2.11

307.65

2.6

2.0

202.2

200.2

u/l

0.03

6147

34766

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3156

15324

2.26

307.65

8.6

5.9

1.1

1.0

mmol/l

0.74

2980

14451

(3013826) Glucose [Moles/volume] in Serum or Plasma

11837

81368

2.14

307.65

6.2

4.1

6.5

mmol/l

1.16

11174

74194

(3027008) Opiates [Presence] in Urine

2173

8851

2.64

307.65

2.9

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

18057

157971

2.74

307.65

20.2

11.3

3.9

mmol/l

0.69

17719

153365

(3019198) Lymphocytes [#/volume] in Blood

11161

78721

1.97

307.65

8.1

5.7

2.0

e9/l

0.44

10038

70683

(3018010) Neutrophils/100 leukocytes in Blood

10425

73511

1.89

307.65

7.8

5.6

56.7

56.4

1.65

9838

69479

(3018095) Leukocytes [#/volume] in Urine

7483

48883

1.86

307.65

4.6

3.2

81.0

77.5

e6/l

0.15

5431

32675

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3949

19822

2.24

307.65

5.1

3.4

0.8

mmol/l

5.08

3711

18637

(3002582) Erythrocytes [#/volume] in Urine

6448

39626

1.93

307.65

3.9

2.8

62.6

75.7

e6/l

0.39

5095

29692

(3015377) Calcium [Moles/volume] in Serum or Plasma

7139

43117

2.03

307.65

3.5

3.3

2.3

2.4

mmol/l

1.53

6301

38516

(3028707) Methadone [Presence] in Urine by Screen method

1486

2420

6.56

307.65

3.2

2.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9501

55696

2.36

307.65

7.7

5.5

1.2

mmol/l

0.62

8851

50855

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5477

32803

1.93

307.65

2.5

2.1

2.9

2.8

mg/l

3.74

4731

28350

(3018418) pH of Serum or Plasma

6452

36477

2.14

307.65

5.2

3.9

7.4

2.97

1434

7140

(3024561) Albumin [Mass/volume] in Serum or Plasma

8872

55981

2.07

307.65

6.0

4.7

36.1

36.4

g/l

8.23

8292

52277

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9010

61160

1.87

307.65

2.8

2.2

9922.0

75.3

nmol/l

0.50

8326

56712

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4350

20535

2.44

307.65

2.2

1.6

1.5

1.3

56.47

3862

18559

(3026008) Bacteria identified in Urine by Culture

6178

39540

1.82

299.36

3.4

2.5

—

(40758558) Short blood count panel - Blood

5816

36676

1.83

295.00

9.0

6.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

13277

106164

1.77

288.69

5.4

3.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17064

147854

2.16

288.68

6.0

4.4

1.8

2.1

mu/l

5.81

16085

138729

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

452

676

6.82

286.78

12.0

12.1

0.6

mmol/l

0.10

417

627

(3009508) Creatinine [Moles/volume] in Urine

6052

38894

1.80

286.68

3.7

3.2

7.8

8.3

mmol/l

0.74

5180

33548

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2184

9805

2.38

279.12

5.5

3.8

5.9

5.8

kpa

1.37

2106

9519

(3012544) pH of Venous blood

2236

10162

2.35

277.84

5.4

3.8

7.4

1.18

(3002032) Base excess in Venous blood by calculation

2163

9761

2.37

272.90

5.6

3.9

1.8

mmol/l

0.19

1781

7985

(3014111) Lactate [Moles/volume] in Serum or Plasma

2123

9560

2.37

268.96

7.4

1.4

1.3

mmol/l

1.03

2027

9256

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2517

12235

2.21

265.71

1.9

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2520

12388

2.19

258.19

1.9

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2731

13906

2.12

255.45

8.2

7.1

104.5

104.6

mmol/l

0.27

2673

13642

(3024354) Oxygen [Partial pressure] in Venous blood

1836

7921

2.45

255.34

4.7

3.2

4.9

4.7

kpa

3.40

1760

7664

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3348

18527

1.97

248.35

2.7

2.1

29.6

29.5

0.44

3246

17996

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5265

33646

1.77

247.20

2.2

1.7

1.2

1.0

mg/l

1.29

3876

25134

(3022948) Iron [Moles/volume] in Serum or Plasma

3558

20137

1.94

246.87

3.0

2.4

13.4

14.2

umol/l

8.45

3295

18859

(3020779) Urea [Moles/volume] in Serum or Plasma

2088

9740

2.28

242.38

11.6

7.8

8.2

8.5

mmol/l

1.29

2017

9351

(3007853) Bacteria identified in Skin by Aerobe culture

3041

16461

2.00

239.54

2.0

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3274

18272

1.95

235.72

3.0

2.4

g/l

0.34

3009

17063

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1905

8651

2.33

235.23

1.9

1.6

—

(3000991) Gas panel - Venous blood

1984

9224

2.28

231.64

9.9

8.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4519

28096

1.79

230.53

3.4

2.7

1013.3

989.2

ng/l

0.13

3754

23362

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1597

6781

2.47

229.00

4.3

3.2

5.2

5.1

kpa

0.56

1511

6289

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

331

454

7.40

227.19

2.4

1.5

193.6

120.0

umol/l

2.11

171

228

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1539

6450

2.50

226.89

4.3

3.1

1.4

1.6

mmol/l

0.93

1118

4666

(3009343) pH of Capillary blood

1578

6696

2.47

226.51

4.3

3.1

7.4

0.54

241

868

(3042936) Bacteria identified in Isolate by Culture

3277

18548

1.92

225.24

2.4

1.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3023

16685

1.96

223.82

3.1

2.5

22.6

24.0

5.77

2633

14402

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2455

12615

2.08

222.01

2.9

2.4

51.0

40.8

u/l

0.22

2095

10898

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13680

113788

1.66

220.94

4.3

2.7

47.1

40.5

u/l

14.95

13009

108379

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

16787

147935

1.92

220.70

16.0

9.5

91.1

89.0

ml/min/173m2

27.58

14287

120734

(3044889) 12 lead EKG panel

12284

99483

1.62

220.66

3.8

3.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18004

162856

2.24

217.09

19.4

10.6

19.3

21.1

mg/l

12.35

15038

124859

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4246

26355

1.78

215.81

1.7

1.6

48251807.9

38406165.2

pmol/l

0.39

3660

22606

(3027801) Oxygen [Partial pressure] in Arterial blood

2375

12198

2.08

214.59

8.1

7.5

12.6

13.2

kpa

6.86

2286

11653

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2374

12203

2.08

213.99

8.1

7.5

5.1

kpa

2.32

2288

11660

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9789

75460

1.59

212.91

3.5

2.8

112.7

96.2

ug/l

3.70

9163

71475

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2273

11623

2.08

207.39

2.8

2.3

0.2

g/l

0.08

2109

10933

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3599

21498

1.83

206.98

3.0

2.4

1.1

1.2

e6/l

0.12

1973

11775

(3017143) Hepatitis C virus Ab [Presence] in Serum

3829

23316

1.80

206.52

2.0

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3422

20145

1.85

206.26

3.2

2.6

4.4

3.4

e6/l

3.86

1810

10482

(3003396) Base excess in Arterial blood by calculation

2349

12206

2.05

205.04

8.2

7.5

0.9

mmol/l

0.05

1889

9444

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1302

5303

2.56

203.24

6.1

4.4

24.0

24.2

mmol/l

1.29

1164

4822

(44816559) Phosphatidylethanol [Mass/volume] in Blood

849

2766

3.16

201.35

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1396

5990

2.43

194.65

1.7

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

9782

76379

1.56

193.95

4.2

3.1

0.0

estimate

1.91

2286

14480

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1994

9978

2.11

191.90

4.8

3.5

1.2

mmol/l

1.20

1794

8797

(3016502) Oxygen saturation in Arterial blood

2098

10747

2.07

189.55

8.7

8.0

95.8

96.1

1.29

2045

10314

(3044640) Blood type and Crossmatch panel - Blood

6497

46534

1.59

185.79

2.9

2.1

—

(3017181) Myelocytes/100 leukocytes in Blood

2222

11714

2.01

185.19

4.9

4.2

1.0

0.9

0.29

644

2923

(3007164) IgA [Mass/volume] in Serum or Plasma

5007

33688

1.65

184.83

1.6

1.4

2.2

g/l

0.53

3013

21929

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2768

15751

1.88

183.86

3.5

2.7

6.6

7.3

umol/l

1.30

2320

13571

(3009261) Glucose [Presence] in Urine by Test strip

9820

77355

1.54

182.69

4.3

3.2

0.0

estimate

0.04

2293

14555

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3514

21546

1.77

182.51

2.9

2.8

2.4

mmol/l

0.04

2999

18926

(3021601) Nitrite [Presence] in Urine by Test strip

9747

76727

1.54

181.40

5.6

4.3

0.0

estimate

0.32

2339

14967

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4352

28401

1.68

180.00

2.4

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1541

7147

2.25

179.11

1.6

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5626

39485

1.59

172.55

1.4

1.3

1.6

u/ml

1.87

1488

11556

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4712

31680

1.64

172.42

2.6

2.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

2114

11222

1.99

172.04

5.0

4.2

0.1

0.02

583

2727

(3013512) EKG study

5047

34584

1.62

170.70

4.0

3.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

448

1065

4.28

169.56

1.8

1.3

1.5

1.4

promille

1.08

332

829

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

952

3627

2.71

169.47

2.5

2.3

358.8

557.0

ug/l

1.20

881

3348

(3023183) Ammonium ion [Moles/volume] in Plasma

689

2220

3.18

166.16

3.1

33.1

35.1

umol/l

1.37

606

1916

(3019150) Specific gravity of Urine by Refractometry

4670

31730

1.62

162.13

4.3

3.4

1.0

kg/l

1.25

585

4887

(3002179) Metamyelocytes/100 leukocytes in Blood

2012

10748

1.97

160.18

4.7

4.0

0.7

0.6

0.06

467

2134

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1923

10134

1.99

159.14

9.0

8.3

122.4

g/l

0.01

1868

9741

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3610

23108

1.69

157.90

4.0

3.1

336.1

481.1

ng/l

1.12

2284

15060

(3020564) Creatinine [Moles/volume] in Serum or Plasma

18389

170851

2.17

156.60

20.6

11.7

72.9

72.0

umol/l

2.63

18384

170767

(3005719) IgG [Mass/volume] in Serum or Plasma

2077

11306

1.94

156.25

3.1

2.6

10.1

10.5

g/l

6.05

1903

10408

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

389

895

4.41

153.57

20.0

18.6

1436.4

3297.9

nmol/l

0.78

369

853

(3025159) Blasts/100 leukocytes in Blood

1984

10725

1.95

152.15

5.1

4.2

0.0

0.3

2.02

510

2316

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1480

7206

2.14

151.50

8.1

7.4

24.6

24.7

mmol/l

0.30

1466

7160

(3048689) Calprotectin [Mass/mass] in Stool

3427

21864

1.69

151.01

2.6

2.5

133.9

121.3

ug/g

1.06

2661

17418

(3042517) Benzodiazepines panel - Urine

150

125

12.08

149.80

3.0

3.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9180

73474

1.47

144.16

4.6

3.8

—

(3019060) Gas panel - Arterial blood

1387

6730

2.14

142.98

5.5

4.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2274

13096

1.83

142.79

5.0

4.2

237.6

236.8

u/l

0.09

2162

12473

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4939

34869

1.56

142.34

2.8

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15458

137519

1.58

142.32

5.8

4.6

39.1

38.4

mmol/mol

15.46

14503

129855

(3027945) Reticulocytes/100 erythrocytes in Blood

2101

11863

1.86

140.41

3.7

2.6

1.8

1.69

1891

10651

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16457

148750

1.65

140.36

4.6

3.7

5.9

5.7

mmol/l

41.49

15287

138974

(3037522) Nuclear Ab [Titer] in Serum

3489

22794

1.65

138.96

1.4

500.6

558.6

titre

1.07

678

4506

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

362

854

4.30

138.35

14.5

12.8

789.4

830.7

nmol/l

0.83

353

818

(3014007) Fractional oxyhemoglobin in Arterial blood

1370

6704

2.12

138.02

10.5

9.7

93.9

94.2

1.40

1365

6678

(3022313) Gas panel - Capillary blood

1078

4815

2.31

136.03

4.8

3.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1301

6327

2.13

133.06

4.1

3.3

129.8

131.0

g/l

1.05

1265

6188

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18420

172534

2.06

132.77

13.9

8.6

27.6

26.6

u/l

7.09

18012

167469

(3029937) Albumin [Presence] in Urine by Test strip

5520

40439

1.51

132.09

4.8

3.4

0.0

estimate

4.51

2277

14576

(3011397) Hemoglobin [Presence] in Urine by Test strip

4764

33825

1.54

132.08

4.0

3.2

—

(40768797) Stomach Pathology biopsy report

2962

18835

1.67

130.21

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1053

4799

2.26

126.50

3.9

2.9

1.6

1.3

9.65

1043

4768

(3015235) Bicarbonate [Moles/volume] in Capillary blood

697

2626

2.71

126.40

3.3

2.7

24.3

24.5

mmol/l

0.52

630

2296

(3023511) Choriogonadotropin [Units/volume] in Urine

1138

5391

2.18

124.25

1.5

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

741

2936

2.58

121.43

8.3

5.6

913.3

1190.8

iu/ml

0.19

115

395

(3028626) Oxygen [Partial pressure] in Capillary blood

663

2488

2.72

121.13

4.2

3.0

8.9

8.7

kpa

3.54

631

2310

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1018

4697

2.23

118.56

3.9

2.9

0.7

0.19

978

4510

(46235355) HIV 1 and 2 tests - Meaningful Use set

5921

44785

1.46

117.75

2.3

1.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

947

4288

2.27

115.36

5.0

3.3

24.6

24.8

mmol/l

1.14

896

3984

(1616796) Gas panel - Central venous blood

665

2567

2.65

114.86

4.4

3.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

850

3697

2.36

113.73

1.4

1.3

523.0

485.1

mg/l

0.36

805

3538

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2124

12772

1.74

113.57

4.1

2.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

736

3003

2.51

113.36

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1582

8709

1.89

113.31

2.1

1.8

1.3

g/l

0.02

1480

8071

(3019225) pH of Specimen

1958

11539

1.77

112.24

5.2

3.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1368

7236

1.96

110.40

2.1

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

955

4424

2.22

109.99

4.8

3.5

50.9

48.9

1.43

945

4373

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2410

15121

1.68

109.98

1.7

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1125

5566

2.08

109.43

10.0

10.1

24.2

mmol/l

0.13

1046

5276

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1574

8747

1.87

109.32

4.8

4.0

94.6

85.4

ng/l

2.41

1377

7755

(3018405) Lactate [Moles/volume] in Arterial blood

821

3583

2.35

108.94

5.6

4.0

1.4

mmol/l

0.15

814

3513

(3002385) Erythrocyte distribution width [Ratio]

15488

140165

1.49

108.92

22.3

12.8

13.6

13.5

10.86

15267

137377

(3027315) Oxygen [Partial pressure] in Blood

675

2700

2.55

108.36

4.8

3.5

9.0

8.9

kpa

0.60

662

2652

(3023520) Reticulocytes [#/volume] in Blood

1535

8491

1.88

108.12

3.4

2.7

74.0

71.3

e9/l

1.77

1173

6300

(3012501) Base excess in Blood by calculation

669

2678

2.55

107.22

4.8

3.4

2.4

2.3

mmol/l

0.39

435

1751

(3020891) Body temperature

909

4170

2.24

107.18

6.9

4.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2166

13296

1.71

107.11

18.3

17.4

1.2

inr

0.01

267

2149

(3013290) Carbon dioxide [Partial pressure] in Blood

669

2680

2.55

107.05

4.8

3.5

5.0

kpa

1.95

656

2633

(3010421) pH of Blood

739

3109

2.43

106.46

4.7

3.5

7.4

4.35

656

2634

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4022

28644

1.51

106.25

1.3

39.2

32.7

iu/ml

0.29

1061

9225

(3020630) Protein [Mass/volume] in Serum or Plasma

1522

8453

1.87

105.77

2.7

2.4

66.4

67.0

g/l

2.12

1415

7818

(3000494) Fungus identified in Specimen by Culture

2567

16540

1.63

105.22

1.7

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

5052

37719

1.46

105.03

5.9

4.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1267

6647

1.97

104.56

8.9

6.8

24.7

24.5

mmol/l

1.01

1214

6140

(3021901) Oxygen saturation in Capillary blood

516

1843

2.85

103.49

3.0

2.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

750

3227

2.38

102.73

1.4

1.3

3.8

3.7

mmol/l

1.69

691

3040

(3012516) Albumin [Mass/volume] in Urine

4620

34209

1.46

99.32

3.7

3.3

391.7

431.8

mg/l

0.24

3075

21508

(3020682) Albumin/Creatinine [Ratio] in Urine

4802

35833

1.45

99.05

4.4

4.1

10.4

9.6

mg/mmol

0.51

3177

22814

(3052851) Hemolysis interference index of Serum or Plasma

822

3737

2.25

98.97

3.3

2.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

746

3271

2.33

97.82

1.5

1.4

623.7

1418.5

e6/l

1.78

611

2659

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

745

3265

2.33

97.80

1.5

1.4

20.4

30.8

e6/l

0.55

575

2526

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

157

240

6.59

97.55

1.8

2.1

15.7

17.3

umol/l

0.82

157

240

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

350

1034

3.43

97.02

3.0

2.7

760.3

766.7

e6/l

0.05

127

446

(3027273) Bicarbonate [Moles/volume] in Venous blood

984

4841

2.09

96.95

4.5

3.2

25.4

25.3

mmol/l

0.27

952

4679

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

573

2234

2.61

96.91

4.2

2.8

741.3

7677.6

u/ml

0.68

(3026250) Tacrolimus [Mass/volume] in Blood

270

668

4.08

96.90

41.4

35.5

7.4

ug/l

0.13

252

615

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1493

8469

1.83

96.64

2.6

2.1

8.9

7.6

ug/l

0.74

1299

7474

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1793

10744

1.74

96.21

3.2

3.5

4.4

4.6

pmol/l

6.29

1549

9743

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

831

3845

2.21

95.81

2.3

2.0

1.6

2.0

ug/l

0.58

758

3423

(3044290) Cell count panel - Cerebral spinal fluid

713

3095

2.35

95.66

1.5

1.4

—

(40761511) CBC panel - Blood by Automated count

18267

172817

1.80

95.46

17.6

9.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1862

11338

1.71

94.17

2.6

2.2

5700.0

6338.6

u/l

0.34

656

4826

(3000570) Elastase.pancreatic [Mass/mass] in Stool

774

3505

2.26

94.02

1.5

1.4

287.0

286.1

ug/g

0.04

432

1948

(21494815) CD4 cells/100 lymphocytes in Specimen

396

1290

3.11

93.57

2.6

2.3

42.0

43.1

0.20

186

(21494755) Public health laboratory ask at order entry panel

1525

25198

0.57

93.05

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2793

18995

1.55

89.77

2.3

1.9

—

(40767503) Oxygen content in Capillary blood by calculation

587

2404

2.49

89.56

3.0

2.3

17.0

16.9

0.27

329

1161

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

576

2348

2.50

88.76

1.4

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

698

3101

2.30

88.69

6.0

4.3

3.8

mmol/l

1.04

661

2922

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

576

2349

2.50

88.68

1.4

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7406

60505

1.36

86.94

4.4

3.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2277

14917

1.60

85.88

2.1

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3740

27235

1.46

85.84

1.3

7.4

11.1

u/ml

3.13

1451

11658

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

310

926

3.39

84.48

1.7

1.4

—

(3036489) Thrombin time

1091

5849

1.92

84.01

2.6

2.1

21.4

21.1

0.70

933

4952

(3037121) Protein [Mass/volume] in Urine

868

4299

2.07

83.81

4.1

3.2

0.3

g/l

0.86

455

1911

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

399

1399

2.89

82.80

7.3

6.3

10.9

11.0

mg/l

0.07

372

1302

(3021387) Prolactin [Units/volume] in Serum or Plasma

1454

8565

1.75

82.37

1.8

1.6

368.4

290.9

mu/l

2.74

1275

7707

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

493

1957

2.56

80.32

2.0

1.7

—

(3011412) CD3 cells [#/volume] in Blood

403

1446

2.82

80.13

2.9

2.5

1.3

1.2

e9/l

1.50

244

840

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

193

430

4.52

79.45

2.1

2.5

145.4

154.5

nmol/l

0.38

165

373

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4820

37198

1.39

78.92

1.7

1.6

1.5

1.4

mmol/l

17.76

4167

32063

(3028271) Lactate [Moles/volume] in Capillary blood

467

1822

2.60

78.84

2.2

1.7

mmol/l

0.39

453

1779

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

748

3592

2.13

78.34

2.1

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

734

3505

2.14

78.00

1.7

1.4

17.2

21.2

u/ml

0.41

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

255

708

3.64

77.76

2.1

1.5

1260796.8

2153094.3

iu/ml

0.52

(3029634) Reagin Ab [Titer] in Serum by VDRL

589

2575

2.33

77.66

2.9

2.0

13.3

6.4

titre

0.61

(40761535) Cells panel - Urine sediment

1630

10070

1.67

77.39

4.2

3.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4820

37386

1.38

76.03

1.9

1.7

—

(3024928) Oxygen saturation in Venous blood

536

2274

2.40

75.66

3.9

3.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

626

2850

2.24

74.95

1.9

1.6

—

(36660697) Celiac disease serology panel - Serum

2080

13764

1.57

74.46

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1154

6549

1.81

74.01

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

1571

9726

1.67

73.85

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

443

1740

2.58

73.78

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2247

15169

1.54

73.53

8.1

5.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

914

4834

1.93

73.13

2.1

1.8

0.2

g/l

0.51

868

4614

(3022145) Colonoscopy Study observation

2358

16114

1.53

72.89

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1150

6557

1.80

72.58

1.3

0.8

1.1

u/ml

0.50

108

566

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

957

5156

1.90

72.40

3.0

2.2

95.7

93.9

1.55

898

4763

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

908

4813

1.93

72.16

2.2

1.8

1.4

g/l

0.17

791

4148

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

605

2765

2.23

71.75

2.0

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

885

4664

1.94

71.54

3.6

2.6

3.4

3.6

g/l

2.47

843

4427

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

931

4990

1.91

71.54

2.1

1.8

1.2

g/l

0.35

889

4770

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

720

3529

2.08

71.39

1.7

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

739

3658

2.06

71.36

1.4

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

505

2151

2.38

70.65

2.5

1.7

6275.1

1863.0

titre

0.93

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

683

3300

2.11

70.34

1.7

1.4

109.2

110.7

u/ml

0.14

139

750

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

700

3465

2.06

67.56

1.4

1.3

281.1

254.9

u/ml

1.48

463

2278

(3003181) Sodium [Moles/volume] in Urine

408

1615

2.56

66.88

1.6

1.4

64.5

64.6

mmol/l

0.01

317

1259

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

748

3815

2.00

66.44

6.7

3.7

1.6

1.4

mg/l

7.52

705

3576

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1695

10989

1.59

65.84

2.4

2.3

25.2

21.0

au/ml

0.63

850

(3026493) Urate [Moles/volume] in Serum or Plasma

4617

36294

1.36

65.10

2.9

2.3

1875.7

3154.4

umol/l

2.89

4069

32356

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

873

4729

1.89

64.86

3.0

2.5

180.2

175.6

0.86

829

4492

(3004588) Protein electrophoresis panel - Serum or Plasma

1139

6727

1.74

63.47

2.6

2.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1571

10094

1.60

63.26

1.3

44.8

44.9

au/ml

0.01

448

(3014765) Yersinia sp identified in Stool by Organism specific culture

833

4481

1.90

63.21

1.2

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

996

5667

1.80

63.14

1.8

1.6

10.9

13.4

u/ml

0.37

160

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

827

4440

1.90

63.13

1.2

1.1

—

(3010503) CD19 cells [#/volume] in Blood

262

846

3.13

62.94

3.0

2.6

0.2

0.3

e9/l

0.65

255

833

(3009214) Lutropin [Units/volume] in Serum or Plasma

1081

6308

1.76

62.84

1.4

10.2

9.6

u/l

0.91

868

5252

(3010375) cycloSPORINE [Mass/volume] in Blood

221

646

3.45

62.40

26.6

26.2

121.3

118.3

ug/l

0.23

175

536

(42529406) Shigella sp [Presence] in Stool by Culture

832

4495

1.89

62.29

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

253

807

3.16

62.05

3.1

2.8

38.5

41.2

0.88

283

(3022806) Fractional oxyhemoglobin in Capillary blood

381

1517

2.54

61.72

2.1

1.6

90.8

90.7

0.15

374

1495

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

300

1060

2.86

61.45

2.4

2.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

318

1172

2.74

60.16

2.4

2.2

74.6

74.1

0.27

304

1131

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

383

1548

2.50

60.12

1.8

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1028

6007

1.75

59.41

10.5

9.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

220

662

3.35

59.37

2.2

1.7

2.0

1.9

umol/l

0.96

206

618

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

647

3265

2.01

59.18

4.7

3.3

0.3

0.4

u/ml

1.23

382

1811

(3006184) Hemoglobin [Mass/volume] in Capillary blood

565

2712

2.12

59.17

2.3

2.1

132.7

132.0

g/l

0.23

431

1990

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5143

41579

1.32

58.76

1.8

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

916

5199

1.80

58.49

2.4

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1023

6033

1.73

57.19

1.8

1.7

—

(40768804) Tissue Pathology biopsy report

7479

63710

1.28

57.05

2.1

1.9

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

109

7.46

56.63

5.4

4.1

2.4

2.5

mg/l

0.14

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

309

1159

2.69

56.52

2.4

2.1

10.4

13.7

5.06

140

579

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1556

10261

1.56

55.76

2.5

2.1

12.0

12.3

nmol/l

0.76

1354

9331

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1049

6275

1.71

55.68

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

542

2622

2.10

55.61

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

333

1309

2.57

55.43

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5437

44619

1.30

54.89

3.8

2.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

326

1294

2.54

53.20

1.5

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

810

4564

1.81

52.94

1.8

1.6

251.9

320.8

titre

0.23

183

(3007566) Smooth muscle Ab [Titer] in Serum

783

4368

1.83

52.88

1.3

78.8

142.0

titre

2.91

438

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

529

2590

2.07

52.57

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

642

3373

1.93

52.26

1.6

1.5

—

(4035726)

1707

11646

1.51

52.17

1.6

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

169

5.70

51.90

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

825

4721

1.78

51.17

2.2

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

451

2101

2.17

51.02

1.7

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

1662

11330

1.51

50.94

1.4

1.3

212.5

222.5

u/ml

0.16

1542

10523

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

285

1084

2.65

50.75

3.2

2.6

569.6

519.6

e6/l

1.02

245

897

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1084

6701

1.65

50.71

1.1

36.3

8.2

u/ml

0.47

107

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

651

3486

1.90

50.03

1.4

1.3

24.7

24.4

u/l

0.09

534

2889

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

314

1266

2.50

49.61

1.1

—

(3042733) HLA Ab [Presence] in Serum

175

514

3.43

49.14

4.1

5.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1620

11084

1.50

48.69

3.1

2.4

70.4

72.5

ml/min/173m2

1.05

618

4046

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

296

1183

2.53

47.66

1.9

1.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

182

562

3.26

47.21

2.3

1.8

27.1

28.8

umol/l

1.32

172

544

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

274

1063

2.60

46.92

3.2

2.7

0.2

e9/l

1.03

244

900

(3034770) Mitochondria Ab [Titer] in Serum

751

4295

1.78

46.65

1.2

1.3

870.4

906.5

titre

0.05

127

(3016650) Hepatitis A virus Ab [Presence] in Serum

530

2719

1.98

46.27

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

855

5086

1.71

46.21

2.1

2.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

653

3591

1.85

46.17

1.4

1.5

4.6

14.5

iu/ml

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

220

776

2.86

45.33

1.9

1.5

18.3

27.2

umol/l

5.53

209

747

(3016018) Differential panel - Cerebral spinal fluid

369

1666

2.24

45.14

1.4

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

763

4429

1.75

45.01

5.1

4.8

1.8

1.7

1.79

724

4124

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

618

3392

1.85

43.96

2.8

2.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1893

13613

1.43

43.80

1.3

1.2

130.6

149.4

iu/ml

1.22

632

5447

(3007930) Methemoglobin/Hemoglobin.total in Blood

748

4357

1.75

43.58

5.2

4.9

0.9

0.00

709

4066

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1251

8293

1.54

43.46

3.4

2.6

147.3

149.7

ng/l

0.08

1117

7412

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

561

2998

1.90

43.39

1.5

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

281

1150

2.46

43.06

1.3

2.0

1.9

mmol/l

0.69

256

1074

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

253

985

2.59

43.05

1.9

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

253

985

2.59

43.05

1.9

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

253

985

2.59

43.05

1.9

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1475

20970

0.68

42.93

1.5

1.6

—

(4010399)

1420

9711

1.50

42.58

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

275

1122

2.47

42.42

1.5

283.1

280.8

mosm/kgh2o

1.05

213

888

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

302

1289

2.36

42.18

1.9

1.6

—

(3017509) Phencyclidine [Presence] in Urine

100

221

4.54

41.77

2.9

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

421

2068

2.06

41.52

1.7

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

260

1044

2.51

41.51

3.3

2.7

—

(3023410) Appearance of Cerebral spinal fluid

342

1550

2.23

41.48

1.7

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

312

1367

2.30

41.04

2.4

2.1

21.2

20.4

nmol/l

0.69

300

1306

(40761536) Microorganisms panel - Urine sediment

1889

13743

1.41

40.81

5.0

3.3

—

(3016228) CD19 cells/100 cells in Blood

173

567

3.07

40.68

2.2

2.1

8.1

9.1

0.63

167

557

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2124

15774

1.39

40.67

4.0

3.8

31.0

32.2

5.01

1588

11437

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

447

2286

1.98

39.41

1.9

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

356

1679

2.14

39.11

1.6

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

107

263

4.09

38.99

6.7

5.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

286

1236

2.33

38.86

4.2

3.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

355

1679

2.13

38.72

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

351

1655

2.14

38.59

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

351

1656

2.14

38.53

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

351

1659

2.14

38.36

1.6

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1667

11988

1.43

38.34

1.4

1.3

24.3

26.0

iu/l

1.31

1386

10451

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

314

1424

2.22

38.07

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1611

11531

1.43

38.01

4.1

4.0

26.0

24.2

ug/l

0.08

1277

8814

(21494814) CD8 cells/100 lymphocytes in Specimen

167

559

3.00

37.89

2.2

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

358

1716

2.11

37.73

1.6

1.4

—

(3045716) Anion gap in Serum or Plasma

147

458

3.23

37.68

2.3

2.5

9.1

9.5

mmol/l

0.64

119

343

(3042631) Mycobacterium sp identified in Specimen

298

1329

2.26

37.62

2.7

2.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

206

779

2.66

37.24

1.0

1.1

3.2

6.7

nmol/l

0.51

169

(3016244) Insulin [Units/volume] in Serum or Plasma

284

1247

2.30

37.21

3.5

3.3

27.3

27.6

mu/l

0.05

272

1183

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

711

4280

1.69

36.74

1.2

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1299

8986

1.48

36.65

1.1

163.4

204.0

titre

0.24

253

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

982

6410

1.56

36.46

2.0

2.1

38.9

39.7

u/l

0.52

887

5853

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

487

2634

1.87

36.33

4.5

2.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

201

766

2.64

35.80

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

192

715

2.70

35.79

11.2

6.1

130.7

5508.4

u/ml

0.69

151

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

135

415

3.27

35.40

2.2

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

564

3219

1.77

35.29

2.6

2.2

0.6

0.7

g/l

0.42

506

2833

(3004809) Band form neutrophils/100 leukocytes in Blood

378

1898

2.01

35.15

3.4

3.1

1.4

0.02

310

1484

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

198

756

2.64

35.14

1.1

—

(3024471) HLA-A [Type]

154

515

3.01

35.04

1.0

—

(3024932) HLA-DR beta [Type]

152

505

3.03

34.98

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

471

2554

1.86

34.86

1.7

1.6

0.7

g/l

0.43

355

1934

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

638

3794

1.70

34.50

2.5

2.1

7.1

7.3

g/l

1.70

510

2895

(3006653) Thiamine [Moles/volume] in Blood

182

673

2.72

34.42

1.3

1.4

137.8

135.1

nmol/l

0.30

182

673

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

637

3791

1.70

34.35

2.5

2.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

459

2491

1.86

33.90

1.4

1.2

56.9

187.1

titre

1.19

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

635

3790

1.70

33.88

2.5

2.1

3.7

3.8

g/l

0.68

484

2736

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

599

3520

1.72

33.83

2.4

2.1

9.9

10.3

g/l

1.38

527

2997

(3051651) Icteric interference index of Serum or Plasma

190

726

2.63

33.69

4.4

3.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

328

1591

2.08

33.54

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

328

1601

2.07

32.99

1.7

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

512

2902

1.78

32.82

1.4

1.2

3.3

3.4

u/ml

0.06

174

990

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

499

2809

1.80

32.73

1.4

1.2

4.7

4.0

u/ml

0.81

240

1247

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

516

2934

1.78

32.72

2.4

2.1

0.0

g/l

0.06

479

2704

(3024891) Influenza virus A+B Ag [Presence] in Specimen

719

4476

1.63

32.60

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

605

3603

1.70

32.55

2.5

2.1

2.9

3.0

g/l

1.49

495

2836

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

485

2725

1.80

32.02

1.2

1.1

119.9

118.6

0.34

445

2489

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

402

2132

1.90

31.90

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

732

4607

1.61

31.74

1.4

1.3

28.4

37.3

u/ml

0.39

310

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

512

2931

1.77

31.73

2.3

2.0

39.3

38.3

g/l

3.30

461

2568

(3007463) Buprenorphine [Presence] in Urine

8.38

31.68

8.1

9.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

326

1615

2.04

31.52

1.5

1.3

6.5

6.6

g/l

0.20

234

1112

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

344

1738

2.00

31.48

1.5

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

389

2054

1.91

31.30

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

325

1614

2.03

31.21

1.6

1.3

0.4

g/l

1.18

235

1114

(3028192) IgG subclass 2 [Mass/volume] in Serum

325

1614

2.03

31.21

1.5

1.3

2.9

3.0

g/l

0.60

231

1115

(4062490)

325

1620

2.02

30.90

1.6

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

341

1731

1.99

30.80

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

136

457

2.99

30.75

2.1

1.8

12373.6

11225.2

u/ml

0.03

(3017569) Oxygen content in Arterial blood

130

426

3.07

30.70

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

498

2858

1.76

30.61

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16605

159375

1.27

30.52

4.8

4.0

2.8

2.9

mmol/l

13.59

15450

150326

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

144

504

2.87

30.27

3.4

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

424

2328

1.84

30.21

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

495

2847

1.76

30.20

4.2

3.2

33.0

45.8

mg/l

1.29

391

2297

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

471

2673

1.78

30.09

2.4

2.1

0.0

g/l

0.24

436

2452

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

423

2324

1.84

30.08

2.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

140

4.80

30.05

7.3

8.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

305

1501

2.05

30.05

1.1

1.2

34.7

40.8

mg/l

2.25

248

1253

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

112

340

3.31

30.04

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1352

9773

1.41

29.97

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1001

14363

0.68

29.92

1.3

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

227

996

2.29

29.89

2.6

2.1

99.8

96.8

0.62

216

911

(3034860) Kappa light chains.free [Mass/volume] in Serum

493

2846

1.75

29.70

4.2

3.2

42.7

67.2

mg/l

0.64

392

2288

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

481

2758

1.76

29.66

4.2

3.2

1.6

2.6

ratio

0.93

251

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

465

2644

1.78

29.52

2.4

2.1

0.0

g/l

0.00

436

2447

(3013139) Helicobacter pylori Ag [Presence] in Stool

1435

10520

1.39

29.28

1.2

—

(3007461) Platelets [#/volume] in Blood

18975

186022

1.56

28.90

28.5

15.5

263.3

259.3

e9/l

14.86

18668

181953

(3030981) Hyaline casts [#/volume] in Urine by Automated count

960

6551

1.49

28.90

3.5

2.4

0.3

0.2

e6/l

0.03

938

6309

(3016038) Potassium [Moles/volume] in Urine

165

637

2.60

28.74

1.5

1.2

34.8

35.0

mmol/l

0.03

146

550

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.56

28.39

3.9

2.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

586

3590

1.65

28.34

1.3

1.2

32.2

42.9

u/ml

1.05

359

(3051611) Lipemic interference index of Serum or Plasma

255

1201

2.14

28.25

4.1

3.1

—

(44790049)

289

1431

2.03

28.03

1.9

1.5

—

(44806118)

289

1432

2.03

27.98

1.9

1.5

—

(44790047)

289

1432

2.03

27.98

1.9

1.5

—

(44790048)

289

1433

2.03

27.93

1.9

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

483

2825

1.73

27.80

1.1

—

(1761868) Lipid panel - Serum or Plasma

5911

66802

0.84

27.72

2.7

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

239

1107

2.17

27.64

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

160

621

2.59

27.59

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

293

1467

2.01

27.57

1.1

235.6

239.1

mg/l

0.12

250

1291

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1117

7932

1.43

27.31

1.4

1.3

214.2

225.0

miu/ml

0.41

443

3994

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

131

462

2.85

27.20

3.8

3.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.61

27.13

3.6

3.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

217

3.79

27.10

1.6

1.4

—

(4306422)

484

2862

1.71

26.78

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

195

841

2.33

26.78

1.5

—

(3035941) MCH [Entitic mass]

18977

186223

1.54

26.68

28.3

15.4

30.2

30.1

3.00

18811

184216

(3024731) MCV [Entitic volume]

18978

186242

1.53

26.59

28.4

15.5

90.5

90.2

17.39

18812

184233

(3049717) Cytology report of Urine Cyto stain

532

3234

1.66

26.54

2.3

2.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

285

1433

2.00

26.52

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

661

4241

1.58

26.45

1.4

1.3

7.2

9.3

u/ml

0.47

108

688

(3044242) Glucose [Moles/volume] in Arterial blood

126

443

2.86

26.33

2.2

2.0

—

(3026361) Erythrocytes [#/volume] in Blood

18978

186270

1.53

26.25

28.5

15.5

4.5

e12/l

51.36

18630

181871

(3008037) Lactate [Moles/volume] in Venous blood

384

2141

1.81

26.09

3.4

2.6

1.5

mmol/l

0.07

374

2090

(3010813) Leukocytes [#/volume] in Blood

18981

186325

1.53

26.01

28.6

15.5

6.9

6.6

e9/l

38.83

18631

181884

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

731

4818

1.54

25.96

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

635

4061

1.58

25.78

2.2

10.6

10.5

mg/l

0.12

586

3831

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

11.26

25.76

1.5

1.6

249.1

192.1

nmol/l

0.28

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

392

2211

1.79

25.63

3.7

3.6

150.6

590.2

u/ml

1.96

355

2021

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

348

1894

1.85

25.57

2.7

3.0

2933.6

397.7

u/ml

0.46

331

1739

(40760888) Immunoglobulin light chains.free panel - Serum

384

2156

1.80

25.50

4.2

3.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

137

513

2.68

25.42

1.6

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

647

4173

1.57

25.32

1.4

1.3

8.4

6.2

u/ml

0.23

455

(3000963) Hemoglobin [Mass/volume] in Blood

18979

186358

1.52

25.31

28.7

15.6

134.6

136.3

g/l

54.52

18814

184364

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

155

620

2.51

25.16

2.2

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

155

620

2.51

25.16

2.2

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

155

620

2.51

25.16

2.2

2.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15770

151206

1.22

25.08

4.0

3.4

1.4

1.3

mmol/l

54.39

14635

142752

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

155

621

2.51

25.07

2.2

2.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

110

369

2.99

25.04

1.5

1.3

16.9

16.7

umol/l

0.10

330

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

136

513

2.66

24.89

1.6

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

395

2256

1.77

24.76

1.8

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

539

3348

1.63

24.71

1.3

1.6

4.9

u/ml

1.85

268

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.01

24.69

4.7

4.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16381

157739

1.23

24.58

4.4

3.7

4.7

4.8

mmol/l

33.01

15342

149694

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

278

1427

1.96

24.43

1.3

1.2

70.8

60.1

u/l

0.90

207

970

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

784

5317

1.49

24.33

1.4

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

243

1191

2.05

24.31

1.1

296.2

289.2

mg/l

0.54

216

1077

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

127

469

2.72

24.24

2.4

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

127

469

2.72

24.24

2.4

2.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

603

2.50

24.11

3.0

2.5

57.0

52.6

umol/l

0.90

127

517

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

239

1168

2.06

24.10

1.5

1.4

1.5

1.4

nmol/l

0.11

218

1044

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

128

477

2.69

24.01

2.5

2.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

157

648

2.43

23.85

3.0

2.3

11.6

9.4

0.94

148

610

(3017315) Amylase [Enzymatic activity/volume] in Urine

168

715

2.36

23.85

1.4

1.3

240.8

307.1

u/l

0.65

157

663

(3014148) Varicella zoster virus Ab [Titer] in Serum

464

2800

1.67

23.84

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

152

622

2.45

23.54

2.7

2.2

30.5

28.7

0.83

145

590

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

112

4.74

23.52

1.1

1.2

47.0

41.5

mg/l

0.81

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

243

1210

2.02

23.30

1.2

—

(4027681)

240

1193

2.02

23.13

1.3

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

351

1978

1.79

23.07

1.3

1.2

2.9

1.2

nmol/l

0.30

345

1920

(3006922) Hepatitis E virus Ab [Presence] in Serum

234

1154

2.04

23.05

1.1

—

(3047181) Lactate [Moles/volume] in Blood

585

3775

1.57

22.87

5.8

5.3

1.4

1.3

mmol/l

1.37

512

3320

(3022493) Free Hemoglobin [Mass/volume] in Plasma

139

553

2.52

22.87

6.5

4.5

73.2

3899.8

mg/l

3.02

103

404

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

349

1970

1.79

22.81

1.2

1.1

94.6

95.8

0.34

327

1867

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

230

1135

2.04

22.62

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

517

3251

1.61

22.57

1.9

1.8

194.5

194.9

pmol/l

0.02

486

3131

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

111

397

2.81

22.55

1.4

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

132

516

2.57

22.53

3.6

3.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

259

1336

1.95

22.48

5.4

9.7

7.1

7.4

mmol/l

0.42

207

1087

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.96

22.45

4.2

2.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

347

1970

1.78

22.26

1.3

1.2

0.1

0.2

nmol/l

1.92

102

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

228

1129

2.03

22.23

1.2

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

11.51

22.22

1.7

1.6

324.6

223.9

nmol/l

0.27

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16267

156860

1.21

22.21

4.4

3.7

1.4

1.5

mmol/l

75.91

15181

148550

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

265

1387

1.92

22.04

3.2

6.8

8.2

nmol/l

0.13

255

1346

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

183

3.73

22.02

2.5

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

159

686

2.33

21.92

1.5

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

126

490

2.58

21.75

3.0

2.2

188.0

172.7

e6/l

0.25

247

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

316

1771

1.80

21.20

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1338

10200

1.33

21.12

1.3

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

172

783

2.21

20.90

1.3

53.6

69.3

1.04

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

510

3258

1.58

20.86

1.3

1.2

10.6

17.4

u/ml

0.32

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

357

2085

1.73

20.77

1.1

1.5

g/l

0.85

329

1901

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

118

455

2.60

20.75

1.2

15.1

20.7

0.36

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

127

508

2.51

20.71

1.4

13.5

14.6

pmol/l

1.32

100

446

(3012920) Ethanol [Mass/volume] in Serum or Plasma

11.01

20.64

1.4

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

865

6174

1.42

20.54

1.6

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

205

1007

2.05

20.47

1.1

1.0

1.1

u/l

0.67

435

(3023419) Bacteria identified in Sputum by Culture

248

1303

1.91

20.43

3.3

2.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

179

836

2.15

20.42

1.4

6.6

6.1

u/l

0.17

154

703

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

714

4927

1.47

20.34

1.8

1.7

41.7

40.6

nmol/l

0.39

696

4844

(40768446) Kidney Pathology biopsy report

141

597

2.37

20.33

2.2

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

212

1061

2.01

20.12

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

153

675

2.28

20.07

1.5

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

172

797

2.17

20.02

2.3

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

232

1203

1.94

19.89

1.2

1.1

ratio

0.38

449

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1303

1.90

19.79

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

770

5420

1.44

19.75

1.7

1.6

0.8

4.8

iu/ml

0.62

161

1074

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1304

1.90

19.75

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

432

2.60

19.71

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

212

1069

1.99

19.71

1.1

—

(3002256) Pathology report gross observation

2355

19445

1.24

19.68

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

430

2676

1.62

19.65

4.3

2.4

0.9

0.8

nmol/l

1.99

357

2284

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

246

1308

1.89

19.57

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

243

1287

1.90

19.56

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3341

28592

1.20

19.54

1.8

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

243

1290

1.89

19.43

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

243

1291

1.89

19.38

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

132

555

2.39

19.36

2.1

2.3

15.1

23.8

umol/l

0.59

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

163

754

2.17

19.08

1.5

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

219

1130

1.95

19.07

1.4

11.3

11.4

umol/l

0.06

204

1087

(3017732) Neutrophils [#/volume] in Blood

1423

11101

1.30

19.02

2.9

2.5

4.2

4.1

e9/l

0.89

1127

9207

(3024869) Neuronal Ab [Presence] in Serum

180

3.51

18.73

1.1

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

337

1997

1.70

18.65

3.6

2.7

7.4

mmol/l

0.01

328

1957

(43055514) Macroprolactin [Presence] in Serum or Plasma

140

615

2.29

18.59

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

349

2100

1.67

18.24

1.6

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

444

2.51

18.16

2.1

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

174

842

2.08

18.16

2.8

2.7

661.6

988.7

u/ml

2.31

169

836

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

8.53

17.99

1.6

1.3

552.4

723.0

nmol/l

0.47

(3011985) Renin [Units/volume] in Plasma

323

1916

1.70

17.83

1.7

1.6

69.5

60.3

mu/l

0.33

287

1738

(3010015) Selenium [Moles/volume] in Serum or Plasma

126

3.98

17.81

2.3

2.0

1.2

1.3

umol/l

0.53

118

(3000093) Morphology [Interpretation] in Blood Narrative

213

1115

1.92

17.81

1.3

1.1

—

(3028433) Virus identified in Specimen by Culture

110

445

2.48

17.59

1.3

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

112

457

2.46

17.59

2.9

2.8

29.2

28.0

umol/l

0.31

349

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

251

1392

1.81

17.53

2.3

1.9

23.9

25.1

mg/l

0.11

376

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

847

6197

1.38

17.43

2.3

—

(4268621)

332

1997

1.67

17.40

2.5

2.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

185

933

1.99

17.26

1.3

1.5

7.2

7.6

ug/l

0.12

172

835

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

431

2773

1.57

17.17

2.6

2.5

88.9

104.5

ug/min

0.38

265

1771

(3023420) DNA double strand Ab [Units/volume] in Serum

310

1838

1.70

17.16

1.8

1.6

37.5

33.6

iu/ml

0.23

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

203

1061

1.92

17.08

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

352

2.65

17.06

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

641

2.19

16.88

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

349

2.64

16.81

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

219

1185

1.86

16.58

1.4

1.3

5.2

5.5

umol/l

0.83

202

1096

(3039162) Centromere protein B Ab [Units/volume] in Serum

344

2115

1.64

16.58

1.3

39.2

53.2

u/ml

0.59

143

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

553

7951

0.69

16.54

1.7

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

559

3832

1.47

16.53

1.5

1.4

0.4

0.5

nmol/l

1.94

446

3063

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

125

552

2.27

16.46

1.2

114.1

109.1

1.31

115

495

(3037756) Immunofixation for Serum or Plasma

313

1884

1.67

16.39

2.2

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

105

432

2.44

16.23

3.9

4.1

—

(3019977) pH of Arterial blood

122

539

2.27

16.06

3.1

2.5

7.4

1.04

183

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

312

2.70

16.02

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

182

939

1.95

15.95

1.9

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

229

1279

1.80

15.68

1.3

122.6

194.9

titre

1.24

217

(40768443) Skin Pathology biopsy report

824

6111

1.36

15.60

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

228

1276

1.80

15.51

1.3

95.0

135.3

titre

—

(3016750) Collection duration of Urine

137

647

2.13

15.32

2.4

2.3

521.2

500.1

min

1.81

107

532

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

133

622

2.15

15.26

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

166

843

1.98

15.25

1.7

1.5

5.0

5.7

u/l

0.30

412

(40768441) Liver Pathology biopsy report

202

1096

1.85

15.21

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

126

578

2.19

15.17

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

422

2.40

15.13

2.7

2.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

181

952

1.91

15.01

2.3

2.0

1.2

1.3

g/24h

0.12

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

389

2524

1.55

15.00

1.1

46.0

4304.4

iu/ml

0.66

100

642

(3000475) Leukocytes [#/volume] in Synovial fluid

441

2941

1.51

14.98

1.7

1.6

14203.5

11146.1

e6/l

0.53

320

2170

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

13679

131252

1.14

14.89

3.8

3.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

314

2.62

14.77

1.4

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

126

585

2.16

14.74

1.5

—

(3045414) Leukocytes [Presence] in Urine

885

6697

1.34

14.69

2.0

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

207

1147

1.81

14.59

3.4

3.0

58.2

56.5

0.48

149

738

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

322

2.58

14.57

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

218

1228

1.78

14.55

1.2

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

290

1769

1.65

14.49

1.3

1.4

361.8

332.5

pmol/l

0.38

233

1382

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

130

616

2.12

14.45

1.2

0.3

g/l

0.61

497

(3006576) Bicarbonate [Moles/volume] in Blood

362

2.47

14.17

5.7

6.3

24.8

25.0

mmol/l

0.13

339

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.09

14.14

1.3

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

455

6584

0.68

14.12

1.4

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

166

867

1.92

14.09

1.8

142.2

129.8

1.06

161

821

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

111

500

2.23

14.02

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

164

855

1.93

14.00

2.5

2.3

704.6

647.9

0.89

130

637

(40761539) Cells [Type] in Urine sediment by Light microscopy

300

2.61

13.95

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

377

2.42

13.93

2.0

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

343

2.48

13.78

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

471

3240

1.46

13.76

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

350

2.46

13.69

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

269

2.68

13.65

1.8

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

224

1298

1.73

13.59

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

407

2729

1.50

13.52

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

119

561

2.13

13.44

1.1

263.2

417.0

ng/l

0.27

125

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

164

3.18

13.35

9.3

10.2

5.6

mmol/l

0.04

164

(3039000) Anion gap in Blood

387

2577

1.51

13.30

7.1

6.5

11.5

11.2

mmol/l

0.77

355

2306

(3018572) Chloride [Moles/volume] in Blood

387

2578

1.51

13.27

7.1

6.5

105.5

105.3

mmol/l

0.33

355

2307

(3008898) HLA-B27 [Presence]

934

7249

1.30

12.97

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

163

3.13

12.82

1.7

1.3

59.5

56.9

0.15

(3028679) Herpes simplex virus Ab [Presence] in Serum

195

1106

1.77

12.78

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

605

4414

1.38

12.75

1.9

2.0

4.2

11.7

iu/l

0.82

223

1812

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

139

3.31

12.67

1.7

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

176

971

1.82

12.65

1.4

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

145

752

1.94

12.63

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1415

17164

0.81

12.54

1.4

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

149

782

1.91

12.53

1.3

1.2

19.9

19.5

u/l

0.05

135

674

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

126

626

2.02

12.41

1.1

92.1

94.5

0.42

283

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

140

722

1.95

12.41

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

398

2.29

12.38

2.1

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.73

12.27

2.4

3.7

—

(3004451) EKG impression Narrative

101

466

2.17

12.10

1.6

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

122

605

2.02

12.09

1.1

95.9

96.4

0.05

277

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

127

640

1.99

12.04

1.2

115.9

110.9

0.63

116

571

(3021788) Differential panel - Synovial fluid

351

2341

1.51

12.02

1.6

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

200

1166

1.72

11.94

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

800

6154

1.31

11.89

3.6

2.9

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.98

11.88

1.8

1.7

194.4

157.6

ug/g

0.54

(3013762) Body weight Measured

4.40

11.87

1.1

—

(3014271) Vancomycin [Susceptibility]

368

2.32

11.86

3.2

2.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

418

2895

1.45

11.85

1.3

1.2

—

(1002224) Polysomnography panel

986

7803

1.28

11.79

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1194

9674

1.25

11.70

3.9

2.9

73.6

40.6

u/ml

0.70

1154

9356

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

250

2.61

11.70

2.5

2.7

44.4

28.5

mg/l

0.27

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

150

808

1.86

11.68

1.3

1.2

96.6

81.6

u/l

0.61

137

712

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

124

627

1.98

11.66

1.0

32.0

41.3

ng/l

2.49

447

(40759632) Porphyrins [Mass/mass] in Stool

9.34

11.65

1.2

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

133

691

1.93

11.57

1.2

1.1

45.2

20.0

u/l

1.21

539

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

336

2.36

11.50

1.6

1.2

154.0

113.3

nmol/l

1.16

261

(3022229) Phosphate [Moles/volume] in Urine

4.17

11.49

1.8

2.5

23.5

20.9

mmol/l

0.27

(3035947) Staphylolysin Ab [Units/volume] in Serum

122

617

1.98

11.48

1.1

3.1

3.7

iu/ml

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

300

2.44

11.46

3.3

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

300

2.44

11.46

3.3

2.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

123

625

1.97

11.42

1.0

894.4

737.8

ng/l

2.79

444

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

207

1235

1.68

11.38

1.3

0.7

1.0

u/ml

0.53

481

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

122

619

1.98

11.38

1.0

256.8

321.9

ng/l

2.63

454

(3019897) Erythrocyte distribution width [Ratio] by Automated count

213

3449

0.61

11.35

2.5

2.2

13.2

13.1

0.59

213

3407

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

161

895

1.81

11.35

1.0

1.1

97.1

94.8

0.42

131

727

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

466

2.13

11.31

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

168

948

1.78

11.27

1.1

1632.5

1440.7

miu/ml

1.26

168

948

(3051593) INR in Capillary blood by Coagulation assay

358

2.30

11.25

3.5

9.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

232

2.63

11.24

2.5

2.6

—

(44813793)

216

1311

1.65

11.13

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

170

967

1.76

11.10

4.6

4.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

100

477

2.10

11.05

2.5

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

162

910

1.79

11.04

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

399

2792

1.44

10.76

1.3

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

131

695

1.89

10.74

1.2

1.1

110.7

80.2

u/l

1.49

103

560

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

144

3.06

10.69

1.6

0.9

2.2

mg/l

1.97

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

662

8622

0.76

10.67

1.4

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1046

12869

0.80

10.57

1.6

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

3.4

2.5

mg/l

0.33

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

2.0

1.8

mg/l

0.10

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

0.8

1.2

mg/l

0.29

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

1.0

2.0

mg/l

1.10

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

0.8

0.9

mg/l

0.10

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

2.0

mg/l

0.01

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

1.8

2.0

mg/l

0.11

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

3.7

4.1

mg/l

0.12

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

140

3.08

10.54

1.6

1.7

2.6

mg/l

0.47

(3025130) Human papilloma virus identified in Specimen

452

3250

1.40

10.47

1.8

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

150

838

1.80

10.44

1.1

8.3

13.0

u/ml

0.80

150

(40768793) Breast Pathology biopsy report

514

3782

1.37

10.36

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

505

3715

1.37

10.20

2.1

2.2

6.6

6.0

umol/l

0.40

372

2694

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

489

3583

1.37

10.13

1.3

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

419

2992

1.41

10.12

1.2

1.1

21.1

10.8

au/ml

0.63

234

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

149

2.96

10.10

4.6

7.7

73.3

70.6

0.30

115

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

5.00

10.02

1.8

2.1

—

(3032057) Clostridioides difficile [Presence] in Stool

217

2.59

9.99

2.2

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

914

7319

1.26

9.95

1.9

1.6

4.3

3.5

mg/l

1.28

725

4831

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

167

979

1.71

9.87

1.2

2.3

17.8

u/ml

2.07

105

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

162

2.84

9.86

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

6.40

9.80

1.2

1.0

—

mmol/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

447

2.06

9.74

1.1

—

(3000492) Spirometry study

1942

16780

1.17

9.72

1.5

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

198

1220

1.63

9.69

1.6

1.5

28.3

35.9

2.21

130

748

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

190

1161

1.64

9.61

1.1

6.9

7.9

iu/ml

0.22

340

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

143

2.94

9.57

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

107

554

1.94

9.49

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

273

2.35

9.34

1.2

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

376

2677

1.41

9.28

4.4

3.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

145

2446

0.59

9.22

1.4

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

281

1898

1.49

9.17

1.4

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

330

2306

1.44

9.04

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

101

523

1.94

8.99

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

142

819

1.74

8.94

3.2

8.2

mg/l

0.03

112

648

(3044941) Cell count panel - Synovial fluid

280

1901

1.48

8.92

1.5

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.70

8.86

3.0

5.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

114

620

1.84

8.75

1.3

316.7

443.3

titre

—

(44806071)

238

2.40

8.75

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

257

1724

1.50

8.70

2.0

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

111

600

1.85

8.69

1.3

63.3

84.1

titre

0.31

(4015189)

245

2.37

8.68

3.0

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

100

523

1.92

8.66

1.7

—

(3049233) Organic acids panel - Urine

10.00

8.64

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

237

1566

1.52

8.63

1.1

—

46.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

163

2.70

8.63

2.0

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

163

2.70

8.63

1.1

1.0

—

(3012565) Volume of 24 hour Urine

123

688

1.79

8.62

2.5

2.2

1967.4

2047.0

0.33

116

633

(3036180) Methadone [Presence] in Urine

5.52

8.48

4.0

3.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

182

1140

1.60

8.40

1.3

1.2

79.9

55.9

u/ml

0.65

(3036603) Volume of Urine

148

881

1.69

8.35

1.6

1.7

1628.3

2045.0

1.97

183

(3017704) Immunofixation for Urine

495

1.92

8.33

2.1

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

185

1167

1.59

8.30

1.3

1.2

31.8

45.9

u/ml

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

130

748

1.74

8.29

2.5

2.7

122.2

138.4

au/ml

0.15

113

(3044927) Protein electrophoresis panel - Urine

144

853

1.69

8.28

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

525

4015

1.32

8.26

3.2

3.7

169.1

1640.9

u/ml

1.40

442

3465

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

182

1145

1.60

8.26

1.3

1.2

43.7

39.4

u/ml

0.12

100

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

167

2.64

8.25

1.1

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.81

8.22

1.1

1.2

1.1

u/field

0.27

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3991

36569

1.11

8.20

1.6

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

228

2.37

8.12

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

153

927

1.66

8.09

2.0

1.8

3.8

3.4

mg/l

0.41

144

886

(3003129) Base excess in Capillary blood by calculation

241

2.33

8.07

1.7

1.6

1.2

0.5

mmol/l

0.66

230

(40765096) Chromosome analysis panel by Banding

318

2.14

8.03

1.2

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

109

3.03

7.97

1.2

1.3

1.4

2.1

ml/s/173m2

0.35

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

313

2.14

7.94

2.2

2.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

130

758

1.72

7.93

1.5

1.6

2.5

7.2

nmol/l

0.82

107

627

(3003694) ABO and Rh group [Type] in Blood

5559

51884

1.10

7.91

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

158

971

1.63

7.91

2.3

2.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

115

2.96

7.89

3.0

2.7

22.3

10.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

533

1.86

7.89

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

166

1035

1.61

7.84

3.1

2.1

—

(3014051) Protein [Presence] in Urine by Test strip

427

3195

1.34

7.84

2.3

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

687

5480

1.26

7.81

1.1

3.9

4.9

u/ml

0.42

883

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.04

7.78

2.0

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

431

1.95

7.74

1.1

5.9

6.0

mg/g

0.07

410

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

221

2.36

7.72

1.1

—

(3034426) Prothrombin time (PT)

112

631

1.78

7.72

1.4

1.2

—

(3045424) Erythrocytes [Presence] in Urine

356

2597

1.38

7.69

1.6

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

170

1073

1.59

7.65

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

145

2.69

7.63

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.16

7.51

2.1

1.3

21.7

35.6

1.14

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

173

1102

1.57

7.49

1.3

1.2

8.6

9.9

u/ml

0.08

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

151

931

1.63

7.49

1.9

2.0

—

(3006270) Folate [Moles/volume] in Blood

165

1040

1.59

7.48

1.1

384.0

397.9

nmol/l

0.40

143

945

(3029075) Extractable nuclear Ab panel - Serum

466

1.89

7.41

1.2

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.85

7.39

1.0

4.6

1.2

u/field

—

(4034850)

593

4680

1.28

7.39

11.3

7.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

283

2.16

7.39

1.7

1.6

0.4

ug/l

0.11

194

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

236

1613

1.47

7.36

1.6

57.3

52.6

0.99

152

1022

(3000012) Reticulocyte production index

103

575

1.80

7.34

1.6

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

123

723

1.71

7.33

1.8

1.6

2.7

2.5

u/field

0.12

533

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

245

1692

1.45

7.25

4.1

4.8

130.6

103.6

u/ml

0.19

557

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

380

1.98

7.20

1.1

87.8

86.8

0.08

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

223

2.29

7.13

5.2

53.3

40.8

ug/min

0.54

159

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

174

2.47

7.13

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

139

2.67

7.12

3.1

2.5

—

(3044009) aPTT.lupus sensitive (LA screen)

187

2.41

7.05

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

175

2.46

7.05

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

196

1308

1.50

6.91

3.1

3.0

0.8

nmol/l

0.87

141

988

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

208

2.31

6.87

2.4

1.3

22.8

64.1

ng/l

2.25

132

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.11

6.84

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

120

715

1.68

6.84

1.1

—

(3020491) Glucose [Moles/volume] in Blood

180

1183

1.53

6.83

1.7

6.4

6.2

mmol/l

0.43

145

895

(3020356) Listeria sp identified in Specimen by Organism specific culture

160

2.50

6.81

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

131

2.67

6.80

1.4

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

116

686

1.70

6.80

1.1

—

(3001556) Androgen free Index in Serum or Plasma

254

2.17

6.77

1.1

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

334

2.01

6.76

1.1

1.2

41.3

3.2

u/ml

0.94

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

117

696

1.69

6.71

1.4

1.5

22.9

20.4

u/ml

0.22

134

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

256

1810

1.42

6.71

1.4

1.2

32.9

31.8

u/l

0.05

229

1604

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

312

4218

0.74

6.67

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

214

1466

1.46

6.65

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

181

1201

1.51

6.58

1.4

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

188

2.34

6.52

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

214

2.25

6.45

1.1

1.4

—

(3047189) Immunofixation for 24 hour Urine

417

1.87

6.44

2.1

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

114

682

1.68

6.43

1.6

5.1

6.2

mmol/24h

—

(40762365) Oxygen content in Arterial blood by calculation

166

2.41

6.32

3.9

2.8

14.6

14.8

ml/dl

0.21

155

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.03

6.32

1.1

1.3

18.4

—

(40757373) Influenza virus identified in Isolate

229

2.19

6.31

2.4

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

219

1526

1.44

6.25

1.1

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

380

1.90

6.20

1.1

65.1

74.9

0.88

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

273

2.05

6.04

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

378

1.88

5.97

2.3

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.04

5.90

2.3

1.4

9.8

13.3

0.51

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

112

2.68

5.90

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

101

2.77

5.87

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

2.50

5.83

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

110

670

1.65

5.83

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

264

2.05

5.80

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

167

1122

1.49

5.78

2.9

2.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

186

2.26

5.77

2.9

2.6

1.1

1.3

mmol/l

0.26

134

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

149

2.42

5.76

1.1

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.23

5.71

2.1

1.3

4.2

0.9

0.84

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

307

1.96

5.69

2.0

1.7

39.0

32.2

u/l

0.18

277

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.97

5.67

2.5

1.7

46.7

43.8

umol/l

0.14

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

552

4466

1.24

5.66

1.5

1.4

137.4

104.3

pmol/l

0.80

538

4348

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

378

1.85

5.66

1.1

1.2

—

(4146454)

161

1079

1.50

5.65

3.0

2.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

322

1.93

5.64

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.88

5.60

1.0

1.1

7.1

12.4

u/l

0.84

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

116

724

1.61

5.60

2.7

2.4

19.2

210.2

ug/l

1.32

111

686

(3022621) pH of Urine by Test strip

1090

9415

1.17

5.54

2.9

2.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

161

1084

1.49

5.54

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

156

1044

1.50

5.53

1.5

1.4

35.2

34.5

g/l

0.27

139

956

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

134

2.47

5.51

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

119

751

1.59

5.49

1.7

1.8

1.1

1.2

nmol/l

0.59

609

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1006

0.53

5.34

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.78

5.29

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

220

2.09

5.27

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

105

651

1.62

5.24

1.5

7.6

4.3

0.78

146

(3010144) Erythrocytes [#/volume] in Synovial fluid

166

1139

1.46

5.22

1.4

31049.0

71570.9

e6/l

1.32

119

774

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

107

668

1.61

5.19

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.75

5.18

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

164

1125

1.46

5.17

2.8

2.9

67.3

68.3

mg/l

0.01

112

815

(3024263) Appearance of Synovial fluid

104

646

1.61

5.16

2.0

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.75

5.08

1.7

3.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

602

7242

0.83

5.01

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

547

4485

1.23

5.00

1.2

1.1

1.9

1.6

u/ml

0.28

263

1757

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

208

1501

1.39

4.97

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

328

2537

1.30

4.94

4.7

3.5

42.1

32.9

u/ml

0.62

311

2443

(3036048) Francisella tularensis Ab [Titer] in Serum

352

1.82

4.93

1.2

1.1

—

180.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

289

1.91

4.89

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

375

1.79

4.88

1.1

—

(4024509)

172

1205

1.43

4.88

1.7

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.34

4.87

1.0

—

(3012441) Differential panel - Pleural fluid

125

822

1.52

4.87

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

594

1.62

4.86

1.1

1.5

20.9

u/ml

0.63

334

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.82

4.80

8.2

10.5

836.6

235.8

e6/l

0.43

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

256

1.96

4.80

1.2

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

141

955

1.48

4.78

1.5

1.4

7163.8

3038.1

e6/l

0.63

109

679

(3005033) Fetal Nuchal fold Thickness US

604

7227

0.83

4.77

1.4

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

528

1.65

4.76

2.1

100.2

157.4

ug/min

0.28

111

(3036782) Glucose [Moles/volume] in Pleural fluid

124

819

1.52

4.74

1.4

1.3

6.4

6.2

mmol/l

0.39

114

753

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

538

1.64

4.69

1.0

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

108

694

1.56

4.68

1.4

1.3

371.9

408.6

u/l

0.31

100

661

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

139

2.30

4.66

2.0

1.9

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.21

4.60

1.4

1.1

—

(3048879) Bone marrow aspiration report

267

1.91

4.60

2.4

2.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.53

4.45

1.1

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2354

21632

1.10

4.42

1.8

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

143

2.24

4.39

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

183

2.08

4.34

2.7

72.2

72.0

pmol/l

0.00

156

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.73

4.33

1.1

1.2

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.50

4.32

1.0

0.1

0.4

u/ml

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

182

2477

0.73

4.24

1.3

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

141

981

1.44

4.21

2.2

1.8

2.2

2.1

u/field

0.07

467

(3013293) Extractable nuclear Ab [Presence] in Serum

262

1.87

4.18

1.8

1.6

—

(3019174) dRVVT (LA screen)

186

2.05

4.17

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

109

2.39

4.13

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

630

7398

0.85

4.07

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

828

9510

0.86

4.02

1.4

1.5

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

10.00

4.01

1.0

—

u/field

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.67

3.98

1.1

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.81

3.94

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

612

1.54

3.92

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2915

27194

1.08

3.89

4.0

3.8

2.7

2.3

ug/l

0.28

2607

24877

(3002619) Bacteria identified in Specimen by Culture

269

1.82

3.88

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.96

3.84

1.7

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

124

860

1.44

3.81

1.5

1.4

61312.8

50254.2

e6/l

0.14

488

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

200

1.95

3.80

1.0

2.0

0.5

u/ml

0.39

150

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.60

3.79

1.0

0.2

0.1

u/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

360

1.70

3.79

1.0

1.1

0.7

4.6

u/ml

1.51

247

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

421

1.64

3.78

2.0

1.6

—

463.8

iu/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

481

4015

1.20

3.77

1.1

5.4

5.9

u/ml

0.30

270

2073

(3021661) Pineapple IgE Ab [Units/volume] in Serum

4.00

3.69

1.0

0.2

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1002

11288

0.88

3.68

1.5

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

296

1.76

3.68

1.3

1.2

389.5

348.1

pmol/l

0.25

224

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.79

3.68

1.8

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

148

1070

1.39

3.62

1.7

1.3

60.8

69.6

umol/l

1.12

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.86

3.62

1.0

1.1

0.2

g/l

0.13

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

358

1.68

3.60

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

135

962

1.41

3.60

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

136

2.13

3.59

3.1

3.3

1.1

1.5

mg/l

0.36

(21494434) Karyotype in Bone marrow

130

921

1.41

3.58

1.3

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.94

3.56

1.3

1.7

0.0

0.1

u/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

190

1433

1.33

3.56

2.3

1.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.50

3.53

1.4

1.2

1.0

0.7

umol/24h

0.13

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

178

1.97

3.51

1.7

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2340

25173

0.92

3.51

1.5

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

138

994

1.39

3.47

1.4

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

243

1.81

3.46

1.3

3.0

3.5

mmol/l

0.60

223

(3003338) MCHC [Mass/volume]

14584

148109

0.94

3.43

23.8

13.1

332.7

333.0

g/l

3.05

14483

147020

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

273

1.76

3.43

1.0

81.8

76.1

ug/l

0.38

230

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

146

2.06

3.40

4.1

3.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

782

8902

0.87

3.40

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1264

0.67

3.38

1.2

1.3

1.4

1.5

g/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

782

8898

0.87

3.38

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

174

1.96

3.37

1.4

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

181

1.94

3.36

2.4

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

781

8884

0.87

3.36

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

778

8851

0.87

3.35

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.24

3.33

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

314

1.69

3.30

1.3

1.2

39.1

38.9

g/l

0.05

159

(3011544) Albumin [Mass/volume] in Pleural fluid

2.62

3.29

1.1

1.2

18.6

17.4

g/l

0.21

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

543

1.51

3.23

1.3

1.2

11.8

13.4

u/l

0.66

503

(3011841) English Walnut IgE Ab [Units/volume] in Serum

198

1.87

3.23

1.0

0.1

1.0

u/ml

0.99

149

(3028717) Thiamine [Mass/volume] in Blood

156

1.99

3.23

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

453

3824

1.19

3.21

1.1

1.2

1.1

u/ml

0.10

203

1596

(3036005) Urine sediment comments by Light microscopy Narrative

5.34

3.19

1.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.86

3.18

14.5

8.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.31

3.16

1.3

18.7

25.6

0.38

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

326

1.66

3.15

1.8

1.4

0.3

nmol/l

0.03

241

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.73

3.15

7.5

6.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

429

1.56

3.09

1.5

1.6

9.9

8.6

ug/l

1.28

429

(4094501)

428

3609

1.19

3.08

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

453

3839

1.18

3.08

1.1

2.6

2.2

u/ml

0.20

124

965

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

456

3870

1.18

3.05

1.9

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

276

1.70

3.04

1.4

1.3

238.0

70.5

mu/l

0.49

215

(40763590) HLA-DQ beta [Type]

2.58

3.03

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.58

3.03

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.50

3.03

3.2

2.4

—

(3009871) Measles virus Ab [Titer] in Serum

683

1.44

3.02

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

315

1.65

3.01

2.4

2.0

1.7

3.2

ug/l

1.01

189

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

270

1.71

2.99

1.0

1.1

0.4

0.1

u/ml

0.27

170

(40758292) HTLV I+II Ab panel - Serum

270

1.71

2.99

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

100

2.20

2.98

1.2

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

248

1.74

2.97

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

107

2.15

2.95

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.47

2.95

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

264

1.71

2.94

1.2

1.4

13.6

13.4

g/l

0.04

204

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

113

815

1.39

2.89

1.1

236.3

184.7

iu/ml

0.77

113

810

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

1.97

2.88

1.1

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

199

1.81

2.88

1.3

1.1

3.7

4.1

pmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

693

7854

0.88

2.87

2.1

1.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

110

2.09

2.77

1.3

—

(3007733) Chloride [Moles/volume] in Urine

3.23

2.77

1.4

1.9

84.7

85.2

mmol/l

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.23

2.77

2.0

1.4

1.8

1.9

mmol/24h

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.50

2.69

1.3

2.1

—

(3006462) Nitrate [Presence] in Urine

709

1.40

2.67

3.4

2.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

257

1.67

2.66

1.2

1.1

0.8

0.9

umol/24h

0.25

131

(40768806) Pleura Pathology biopsy report

118

871

1.36

2.65

1.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

163

1261

1.30

2.65

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

16026

158478

1.06

2.65

19.4

11.2

39.9

40.3

9.60

12150

127849

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

577

1.44

2.64

1.7

58.2

154.4

au/ml

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

133

1.96

2.64

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.65

2.62

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

228

1.71

2.61

3.0

2.3

6.8

8.0

mmol/l

1.04

127

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.46

2.61

1.2

1.3

47.5

1812.4

u/l

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

369

1.55

2.57

1.4

53.3

48.2

0.42

318

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

121

1.98

2.54

3.0

2.9

125.5

46.0

pmol/l

—

(40760410) HLA-B [Type] by High resolution

2.42

2.53

1.0

—

(40760409) HLA-A [Type] by High resolution

2.42

2.53

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

101

2.08

2.52

2.0

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

122

1.97

2.49

1.0

0.1

2.1

u/ml

1.10

(3005011) Chlamydia sp Ab [Titer] in Serum

247

1.66

2.48

1.5

—

(36303858) Crystals [Presence] in Urine

4.38

2.47

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

375

1.52

2.41

1.9

2.0

493.6

3094.7

e6/l

0.62

243

(3016273) Islet cell 512 Ab [Units/volume] in Serum

138

1.89

2.40

1.2

1.0

—

(3013862) HLA-DP [Type]

2.34

2.38

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.06

2.36

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.04

2.31

1.1

1.4

—

(40768795) Lymph node Pathology biopsy report

175

1394

1.26

2.30

1.3

1.2

—

(3035880) pH of Pleural fluid

428

1.47

2.30

1.3

—

(3016135) IgD [Mass/volume] in Serum

2.86

2.30

1.3

1.8

89.0

90.5

mg/l

—

(4211845)

105

782

1.34

2.28

3.4

2.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

215

1.68

2.27

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

134

1.87

2.25

1.0

1.1

—

3.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

2.24

0.0

2.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.10

2.22

1.2

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

128

1.88

2.20

1.3

1.7

2.1

mmol/l

0.12

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

280

1.57

2.18

1.4

59.9

60.3

0.02

236

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

218

1.65

2.17

2.8

2.6

—

(3045788) Cell count panel - Pleural fluid

100

746

1.34

2.17

1.7

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.02

2.15

2.1

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.69

2.15

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

436

1.45

2.12

2.7

2.6

83.3

103.0

ng/l

0.63

243

(3001893) Eosinophils/100 leukocytes in Pleural fluid

243

1.61

2.12

1.2

1.4

3.8

2.9

0.24

212

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.36

2.11

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

843

7666

1.10

2.10

1.6

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.70

2.10

6.9

9.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.00

2.10

6.7

4.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

102

1.96

2.09

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

198

1.67

2.07

1.2

89.0

287.5

ug/l

0.82

110

(1617658) Protocol used for examination of sentinel lymph nodes

150

1191

1.26

2.07

1.0

—

(3032641) Amino acids panel - Urine

4.00

2.04

1.5

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

4.00

2.04

1.2

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

399

1.45

2.03

1.2

1.0

0.8

2.5

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

132

1.82

2.03

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

450

1.42

2.00

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

417

1.44

2.00

1.2

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

4.55

1.94

1.0

387.2

279.0

nmol/l

—

(3049242) von Willebrand panel - Platelet poor plasma

2.56

1.92

1.2

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.56

1.92

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.18

1.88

1.1

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.18

1.88

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

260

1.54

1.85

3.6

4.7

39.3

56.9

u/l

0.80

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

260

1.54

1.85

1.2

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.53

1.83

1.5

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.92

1.79

1.3

1.5

345.2

311.5

umol/24h

0.34

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

175

1445

1.21

1.74

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

228

1931

1.18

1.73

1.4

11.4

11.5

mmol/l

0.06

308

(3020618) Glucose [Moles/volume] in Synovial fluid

2.67

1.72

1.0

5.6

5.3

mmol/l

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.92

1.72

1.1

1.2

1.7

1.4

mg/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.95

1.69

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

333

1.44

1.66

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

333

1.44

1.66

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

333

1.44

1.66

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

333

1.44

1.66

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

119

1.77

1.65

1.3

1.4

16.1

10.8

0.30

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.57

1.61

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

336

1.43

1.60

1.9

—

(3025315) Body weight

113

1.77

1.60

4.0

3.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.91

1.59

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

190

1.58

1.59

1.4

22.9

24.9

0.13

158

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

256

1.49

1.54

2.5

2.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

107

1.78

1.54

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.97

1.53

1.0

0.0

u/ml

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.59

1.51

1.0

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

350

3097

1.13

1.51

1.1

2.8

2.9

u/ml

0.06

120

1711

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.07

1.49

38.3

10.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

2.43

1.47

1.0

—

0.6

—

(3016031) Almond IgE Ab [Units/volume] in Serum

147

1.63

1.47

1.0

0.2

0.5

u/ml

1.33

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

284

1.44

1.46

15.5

7.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

203

1.53

1.45

1.6

6.0

418650.3

nmol/l

2.12

177

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

726

1.27

1.43

2.1

2.0

8.1

9.8

mg/l

2.34

590

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.92

1.43

2.9

3.3

—

(40762887) Creatinine [Moles/volume] in Blood

2.73

1.43

1.3

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

103

1.75

1.40

1.1

19.0

23.8

u/l

0.57

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.25

1.40

1.0

1.1

199.7

265.6

nmol/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

373

3337

1.12

1.37

1.1

4.8

4.9

u/ml

0.02

161

1321

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

158

1.58

1.37

1.0

0.4

1.3

u/ml

0.58

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.20

1.36

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.61

1.36

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.04

1.32

1.5

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

334

1.38

1.30

1.4

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.76

1.28

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.78

1.28

1.0

1.1

642.0

1608.3

titre

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

337

1.37

1.24

1.7

1.8

3465.8

15055.5

e6/l

0.93

161

(3018291) Platelet Ab [Presence] in Serum

2.40

1.24

1.2

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

163

1.53

1.22

1.2

1.8

1.9

mmol/l

0.30

(3023430) Cat dander IgE Ab [Units/volume] in Serum

349

3138

1.11

1.21

1.1

7.4

5.0

u/ml

1.06

156

1325

(3002331) Protein [Mass/volume] in Peritoneal fluid

230

1.44

1.19

1.5

1.4

29.5

25.5

g/l

0.70

176

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.88

1.17

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.88

1.17

1.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.70

1.17

1.9

2.0

36.4

60.2

—

(3001729) Color of Synovial fluid

1.70

1.17

1.3

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.77

1.16

1.1

1.0

6.2

13.3

iu/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

335

3015

1.11

1.16

4.0

3.0

22.3

25.1

mg/l

0.78

196

1837

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

2.50

1.15

2.6

1.3

739.8

3241.8

umol/l

—

(3020650) Glucose [Presence] in Urine

531

0.73

1.14

1.9

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

152

1772

0.86

1.13

1.4

26.8

32.4

nmol/l

1.83

131

1641

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.78

1.10

1.8

1.9

18.3

18.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

1107

0.82

1.10

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

607

0.76

1.10

3.6

3.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.26

1.10

3.4

2.0

1.2

2.7

mu/l

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

606

0.76

1.09

7.2

6.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.95

1.08

1.0

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

513

1.27

1.08

2.1

2.0

5.6

3.4

ug/l

0.44

458

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.19

1.08

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

261

1.38

1.07

16.7

7.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.12

1.05

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

231

2599

0.89

1.05

1.6

8.0

7.5

mmol/l

2.54

137

1578

(3044007) Cell count panel - Peritoneal fluid

305

1.34

1.04

1.7

1.9

—

(3025577) Chromium [Mass/volume] in Blood

498

1.27

1.04

2.3

2.1

3.5

2.4

ug/l

0.42

429

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

220

1.41

1.04

1.0

1.1

0.2

0.9

u/ml

0.75

115

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

125

1062

1.18

1.03

7.3

6.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.27

1.03

1.2

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

221

1.40

1.02

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

662

1.22

1.01

1.3

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

155

1.48

1.00

1.2

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.84

0.98

1.1

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.80

0.98

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

117

1.54

0.93

1.5

1.3

—

349.1

—

(44806420)

217

1.38

0.93

1.9

2.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

464

4301

1.08

0.91

1.5

1.3

3.2

3.5

ug/l

0.39

422

3940

(3022689) Creatine [Moles/volume] in Urine

392

1.28

0.91

1.5

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

839

1.18

0.88

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

152

1.45

0.87

2.8

2.0

0.6

0.8

u/field

0.24

152

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.00

0.87

2.3

2.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

694

1.20

0.86

1.0

6.4

11.0

u/ml

1.14

(3037556) Urate [Mass/volume] in Serum or Plasma

334

1.29

0.85

1.5

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

221

1.36

0.85

2.2

2.6

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

222

1.35

0.83

1.0

0.0

2.4

u/ml

0.72

111

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.88

0.81

1.0

1.1

—

(4212803)

1.61

0.81

1.2

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.70

0.80

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

833

7937

1.05

0.74

1.5

—

(4133840)

480

0.79

0.72

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.58

0.71

1.0

1.1

37.1

52.5

u/l

0.81

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.92

0.70

1.0

1.2

1.6

2.7

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

248

1.29

0.68

1.0

0.2

u/ml

0.01

144

(3009015) Lactate [Moles/volume] in Synovial fluid

119

1.43

0.66

1.1

1.3

4.7

5.6

mmol/l

—

(40768800) Prostate Pathology biopsy report

120

1353

0.89

0.65

1.2

—

(4281824)

187

1704

1.10

0.62

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.55

0.62

1.1

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

1.67

0.61

1.2

1.1

136.2

15.7

mu/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

130

1.38

0.61

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.54

0.59

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

400

1.20

0.58

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

400

1.20

0.58

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

400

1.20

0.58

1.3

1.1

—

(3014891) Appearance of Pleural fluid

1.43

0.56

2.3

1.7

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.58

0.56

1.4

3.0

—

0.0

—

(40758358) Immune stain study

1.43

0.52

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

392

3709

1.06

0.51

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

269

1.23

0.51

1.3

1.2

146.3

72.1

mg/l

0.21

200

(3022475) Manganese [Moles/volume] in Blood

109

1.38

0.50

1.3

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

288

2702

1.07

0.50

1.1

1.0

0.1

0.5

u/ml

2.99

542

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.43

0.49

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.49

0.47

1.6

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

120

1316

0.91

0.45

1.1

1.0

0.6

0.8

u/ml

0.18

167

(3003740) Influenza virus B Ag [Presence] in Specimen

390

3709

1.05

0.45

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

147

1353

1.09

0.44

1.3

214.7

133.0

pmol/l

0.23

398

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

130

1.31

0.43

1.5

1.1

1.8

umol/24h

0.07

130

(3038177) Helicobacter pylori Ab [Presence] in Serum

334

3168

1.06

0.43

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

696

1.12

0.43

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

106

1164

0.91

0.42

1.4

5.6

5.3

mmol/l

1.46

100

1108

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.36

0.40

1.3

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.43

0.39

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

325

1.17

0.39

1.3

45.0

40.9

0.25

228

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.39

0.38

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

281

2953

0.95

0.36

1.4

7.0

6.8

mmol/l

0.50

208

2153

(3035933) Granulocytes/100 leukocytes in Blood

556

1.12

0.34

3.0

1.7

—

(3011325) HIV 1+2 Ab [Presence] in Serum

100

1.30

0.33

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

228

1.18

0.33

1.1

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

146

1.23

0.32

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

192

1.20

0.32

6.2

7.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

102

1100

0.93

0.30

1.6

1.8

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.32

0.30

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.71

0.30

1.1

8.7

8.2

mmol/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

111

1.26

0.30

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.23

0.29

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1563

15880

0.98

0.27

2.6

2.5

0.6

0.7

ug/l

2.22

987

8628

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.28

0.23

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

209

1.15

0.22

1.0

0.1

0.6

u/ml

1.76

115

(3029396) Erythrocyte agglutination [Presence] in Blood

886

0.94

0.22

3.2

3.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2136

21598

0.99

0.21

3.6

3.4

21.2

21.6

0.59

789

8357

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

364

1.10

0.20

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

187

0.86

0.20

1.6

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.20

0.19

1.2

1.1

—

(3034614) HLA Ag [Interpretation]

1.15

0.19

1.8

1.1

—

(3000285) Sodium [Moles/volume] in Blood

128

1.17

0.18

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

149

1.14

0.15

1.1

1.4

—

7.5

—

(3015183) Erythrocyte sedimentation rate

116

1114

1.04

0.15

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.81

0.14

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

141

1.13

0.13

1.0

1.1

2.4

7.2

u/ml

—

105

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.82

0.13

1.8

1.3

1.5

1.6

mg/l

—

(40762814) Titanium [Mass/volume] in Blood

142

1.13

0.12

1.9

2.4

5.8

3.7

ug/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

144

1396

1.03

0.12

1.1

1.0

13.2

1.5

u/ml

0.94

364

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

123

1.14

0.12

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

619

1.05

0.12

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

251

0.92

0.12

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

1.04

0.09

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

258

0.93

0.09

1.5

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

144

1406

1.02

0.09

1.1

1.0

8.3

2.2

u/ml

0.93

318

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

164

1675

0.98

0.08

2.2

1.7

—

(3003577) Lead [Moles/volume] in Blood

147

1.09

0.07

1.4

1.5

0.1

0.3

umol/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

295

0.95

0.06

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

162

0.93

0.06

1.2

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

120

1.08

0.04

1.0

1.1

19.1

u/ml

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

230

0.96

0.03

6.4

6.1

—

(3051101) Glucose [Moles/volume] in Cord blood

174

1.03

0.00

5.7

5.6

—

(4038314)

174

0.98

0.00

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

664

0.99

0.00

1.1

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.87

0.00

3.8

7.2

—

(3037201) Protein S Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

76.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.00

0.00

1.0

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

76.7

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.3

—

21.2

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_STRESSOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_STRESSOTH	2.553 [2.31, 2.82]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.085

During the follow-up period (1.1.1998 — 31.12.2019), 8066 out of 79498 females with F5_STRESSOTH died.

Males

Parameter	HR [95% CI]	p-value
F5_STRESSOTH	2.703 [2.46, 2.97]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 6416 out of 46788 males with F5_STRESSOTH died.

Mortality risk

Mortality risk for people of age

years, who have F5_STRESSOTH.

N-year risk	Females	Males
1	0.25%	0.367%
5	1.428%	2.63%
10	3.233%	6.752%
15	6.242%	12.629%
20	10.994%	20.532%

Relationships between endpoints

↥

Index endpoint: F5_STRESSOTH – Other reaction to severe stress, and adjustment disorders

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other reaction to severe stress, and adjustment disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints